Table of Contents
National List of Essential Medicines 2015
Section 1–Anesthetic agents
Read Next
Section 2–Analgesics, antipyretics, non steroidal anti inflammatory medicines, medicines used to treat gout and disease-modifying agents used in rheumatoid disorders
Section 3–Antiallergics and medicines used in anaphylaxis
Section 4–Antidotes and other substances used in poisoning
Section 5–Anticonvulsants/ Antiepileptics
Read Next
Section 6–Anti infective medicines
Section 7–Antimigraine medicines
Section 8 –Antineoplastic/ immunosuppressives and medicines used in palliative care
Read Next
Section 9–Antiparkinsonism medicines
Section 10–Medicines affecting blood
Section 11–Blood products and Plasma substitutes
Section 12–Cardiovascular medicines
Section 13–Medicines used in dementia
Section 14–Dermatological medicines (Topical)
Section 15 –Diagnostic agents
Section 16–Dialysis solutions
Section 17–Disinfectants and antiseptics
Section 18–Diuretics
Section 19–Ear, nose and throat medicines
Section 20–Gastrointestinal medicines
Section 21–Hormones, other endocrine medicines and contraceptives
Section 22–Immunologicals
Section 23–Muscle relaxants and cholinesterase inhibitors
Section 24–Medicines for neonatal care
Section 25–Ophthalmological Medicines
Section 26–Oxytocics and Antioxytocics
Section 27–Psychotherapeutic medicines
Section 28–Medicines acting on the respiratory tract
Section 29–Solutions correcting water, electrolyte disturbances and acid-base disturbances
Section 30–Vitamins and minerals
Alphabetical list of medicines in NLEM 2015
Medicines Added to NLEM 2011
Alphabetical List of Medicines Added to NLEM 2011
Medicines Deleted from NLEM 2011
Alphabetical List of Medicines Deleted from NLEM 2011
INDEX
National List of Essential Medicines 2015
Section 1–Anesthetic agents
1.1–General Anesthetics and oxygen
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 1.1.1 | Halothane | S,T | Inhalation | |
| 1.1.2 | Isoflurane | S,T | Inhalation | |
| 1.1.3 | Ketamine | P,S,T | Injection 10 mg/ml | |
| Injection 50 mg/ml | ||||
| 1.1.4 | Nitrous oxide | P,S,T | Inhalation | |
| 1.1.5 | Oxygen | P,S,T | Inhalation (Medicinal gas) | |
| 1.1.6 | Propofol | P,S,T | Injection 10 mg/ml | |
| 1.1.7 | Sevoflurane | T | Inhalation | |
| 1.1.8 | Thiopentone | P,S,T | Powder for Injection 0.5 g | |
| Powder for Injection 1 g | ||||
1.2–Local anesthetics
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Injection 0.25% | ||||
| 1.2.1 | Bupivacaine | S,T | Injection 0.5% | |
| Injection 0.5% with 7.5% glucose | ||||
| Topical forms 2-5% | ||||
| 1.2.2 | Lignocaine | P,S,T | Injection 1% | |
| Injection 2% | ||||
| Injection 5% with 7.5% Glucose | ||||
| Injection 1% (A) + 1:200000 (5 | ||||
| 1.2.3 | Lignocaine (A) + | P,S,T | mcg/ml) (B) | |
| Adrenaline (B) | Injection 2% (A) + 1:200000 (5 | |||
| mcg/ml) (B) | ||||
| 1.2.4 | Prilocaine (A) + | T | Cream 2.5% (A) + 2.5% (B) | |
| Lignocaine (B) | ||||
| 1.3–Preoperative medication and sedation for short term procedures | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 1.3.1 | Atropine | P,S,T | Injection 0.6 mg/ml | |
| 1.3.2 | Glycopyrrolate | S,T | Injection 0.2 mg/ml | |
| .3.3 | Midazolam | P,S,T | Oral liquid 2 mg/ml | |
| Injection 1 mg/ml | ||||
| Injection 5 mg/ml | ||||
| 1.3.4 | Morphine | P,S,T | Injection 10 mg/ml | |
| Injection 15 mg/ml | ||||
Section 2–Analgesics, antipyretics, non steroidal anti inflammatory medicines, medicines used to treat gout and disease modifying agents used in rheumatoid disorders
2.1– Non-opioid analgesics, antipyretics and nonsteroidal anti-inflammatory medicines
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Acetylsalicylic | Tablet 300 mg to 500 mg | |||
| 2.1.1 | P,S,T | Effervescent/ Dispersible/ Enteric | ||
| acid | ||||
| coated Tablet 300 mg to 500 mg | ||||
| 2.1.2 | Diclofenac | P,S,T | Tablet 50 mg | |
| Injection 25 mg/ml | ||||
| Tablet 200 mg | ||||
| 2.1.3 | Ibuprofen | P,S,T | Tablet 400 mg | |
| Oral liquid 100 mg/5 ml | ||||
| Capsule 250 mg | ||||
| 2.1.4 | Mefenamic acid | P,S,T | Capsule 500 mg | |
| Oral liquid 100 mg/5 ml | ||||
| .3.3 | Midazolam | P,S,T | Oral liquid 2 mg/ml | |
| Injection 1 mg/ml | ||||
| Injection 5 mg/ml | ||||
| 1.3.4 | Morphine | P,S,T | Injection 10 mg/ml | |
| Injection 15 mg/ml | ||||
Section 2–Analgesics, antipyretics, non steroidal anti inflammatory medicines, medicines used to treat gout and disease modifying agents used in rheumatoid disorders
2.1– Non-opioid analgesics, antipyretics and nonsteroidal anti-inflammatory medicines
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Acetylsalicylic | Tablet 300 mg to 500 mg | |||
| 2.1.1 | P,S,T | Effervescent/ Dispersible/ Enteric | ||
| acid | ||||
| coated Tablet 300 mg to 500 mg | ||||
| 2.1.2 | Diclofenac | P,S,T | Tablet 50 mg | |
| Injection 25 mg/ml | ||||
| Tablet 200 mg | ||||
| 2.1.3 | Ibuprofen | P,S,T | Tablet 400 mg | |
| Oral liquid 100 mg/5 ml | ||||
| Capsule 250 mg | ||||
| 2.1.4 | Mefenamic acid | P,S,T | Capsule 500 mg | |
| Oral liquid 100 mg/5 ml | ||||
| Tablet 500 mg | ||||
| Tablet 650 mg | ||||
| All licenced oral liquid dosage | ||||
| 2.1.5 | Paracetamol | P,S,T | forms and strengths | |
| Injection 150 mg/ml | ||||
| Suppository 80 mg | ||||
| Suppository 170 mg | ||||
| 2.2–Opioid analgesics | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 2.2.1 | Fentanyl | S,T | Injection 50 mcg/ml | |
| Tablet 10 mg | ||||
| 2.2.2 | Morphine | P,S,T | Injection 10 mg/ml | |
| Injection 15 mg/ml | ||||
| Capsule 50 mg | ||||
| 2.2.3 | Tramadol | S,T | Capsule 100 mg | |
| Injection 50 mg/ml | ||||
| 2.3–Medicines used to treat gout | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 2.3.1 | Allopurinol | P,S,T | Tablet 100 mg | |
| Tablet 300 mg | ||||
| 2.3.2 | Colchicine | P,S,T | Tablet 0.5 mg | |
2.4–Disease modifying agents used in rheumatoid disorders
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 2.4.1 | Azathioprine | S, T | Tablet 50 mg | |
| 2.4.2 | Hydroxychloroqui | S,T | Tablet 200 mg | |
| ne | Tablet 400 mg | |||
| 2.4.3 | Leflunomide | S,T | Tablet 10 mg | |
| Tablet 20 mg | ||||
| Tablet 5 mg | ||||
| 2.4.4 | Methotrexate | S,T | Tablet 7.5 mg | |
| Tablet 10 mg | ||||
| Injection 25 mg/ ml | ||||
| 2.4.5 | Sulfasalazine | S, T | Tablet 500 mg | |
Section 3–Antiallergics and medicines used in anaphylaxis
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 3.1 | Adrenaline | P,S,T | Injection 1 mg/ml | |
| 3.2 | Cetirizine | P,S,T | Tablet 10 mg | |
| Oral liquid 5 mg/5 ml | ||||
| 3.3 | Chlorpheniramine | P,S,T | Tablet 4 mg | |
| Oral liquid 2 mg/5 ml | ||||
| 3.4 | Dexamethasone | P,S,T | Tablet 0.5 mg | |
| Injection 4 mg/ml | ||||
| 3.5 | Hydrocortisone | P,S,T | Powder for Injection 100 mg | |
| 3.6 | Pheniramine | P,S,T | Injection 22.75 mg/ml | |
| Tablet 5 mg | ||||
| Tablet 10 mg | ||||
| 3.7 | Prednisolone | P,S,T | Tablet 20 mg | |
| Oral liquid 5 mg/5 ml | ||||
| Oral liquid 15 mg/5 ml | ||||
| Section 4–Antidotes and other substances used in poisoning | ||||
| 4.1–Nonspecific | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 4.1.1 | Activated charcoal | P,S,T | Powder (as licensed) | |
| 4.2–Specific | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 4.2.1 | Atropine | P,S,T | Injection 1 mg/ml | |
| 4.2.2 | Calcium gluconate | P,S,T | Injection 100 mg/ml | |
| 4.2.3 | Desferrioxamine | S,T | Powder for Injection 500 mg | |
| 4.2.4 | Dimercaprol | S,T | Injection 50 mg/ml | |
| Methylthioninium | ||||
| 4.2.5 | chloride | S,T | Injection 10 mg/ml | |
| (Methylene blue) | ||||
| 4.2.6 | N-acetylcysteine | P,S,T | Sachet 200 mg | |
| Injection 200 mg/ml | ||||
| 4.2.7 | Naloxone | P,S,T | Injection 0.4 mg/ml | |
| 4.2.8 | Neostigmine | P,S,T | Injection 0.5 mg/ml | |
| 4.2.9 | Penicillamine | S,T | Capsule 250 mg | |
| 4.2.10 | Pralidoxime | P,S,T | Injection 25 mg/ml | |
| chloride (2-PAM) | ||||
| Snake venom | ||||
| antiserum | ||||
| 4.2.11 | a) Soluble/ liquid | P,S,T | a) Injection | |
| polyvalent | ||||
| b) Lyophilized | b) Powder for Injection | |||
| polyvalent | ||||
| 4.2.12 | Sodium nitrite | S,T | Injection 30 mg/ml | |
| 4.2.13 | Sodium | S,T | Injection 100 mg/ml |
Section 5–Anticonvulsants/ Antiepileptics
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Tablet 100 mg | ||||
| Tablet 200 mg | ||||
| CR Tablet 200 mg | ||||
| 5.1 | Carbamazepine | P,S,T | Tablet 400 mg | |
| CR Tablet 400 mg | ||||
| Oral liquid 100 mg/5 ml | ||||
| Oral liquid 200 mg/5 ml | ||||
| 5.2 | Clobazam | S,T | Tablet 5 mg | |
| Tablet 10 mg | ||||
| Oral liquid 2 mg/5 ml | ||||
| 5.3 | Diazepam | P,S,T | Injection 5 mg/ml | |
| Suppository 5 mg | ||||
| Tablet 250 mg | ||||
| Tablet 500 mg | ||||
| 5.4 | Levetiracetam | S,T | Tablet 750 mg | |
| ER Tablet 750 mg | ||||
| Oral liquid 100 mg/ml | ||||
| Injection 100 mg/ml | ||||
| Tablet 1 mg | ||||
| 5.5 | Lorazepam | P,S,T | Tablet 2 mg | |
| Injection 2 mg/ml | ||||
| 5.6 | Magnesium | S,T | Injection 500 mg/ml |
| 5.7 | Phenobarbitone | P,S,T | Tablet 30 mgTablet 60 mgOral | |
| liquid 20 mg/5 ml | ||||
| S,T | Injection 200 mg/ml | |||
| Tablet 50 mg | ||||
| Tablet 100 mg | ||||
| Tablet 300 mg | ||||
| 5.8 | Phenytoin | P,S,T | ER Tablet 300 mg | |
| Oral liquid 30 mg/5 ml | ||||
| Oral liquid 125 mg/5 ml | ||||
| Injection 25 mg/ml | ||||
| Injection 50 mg/ml | ||||
| Tablet 200 mg | ||||
| Tablet 300 mg | ||||
| 5.9 | Sodium valproate | P,S,T | CR Tablet 300 mg | |
| Tablet 500 mg | ||||
| CR Tablet 500 mg | ||||
| Oral liquid 200 mg/5ml | ||||
| T | Injection 100 mg/ml | |||
| Section 6–Anti infective medicines | ||||
| 6.1–Anthelminthics | ||||
| 6.1.1–Intestinal anthelminthics | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 6.1.1.1 | Albendazole | P,S,T | Tablet 400 mg | |
| Oral liquid 200 mg/5 ml | ||||
| 6.1.1.2 | Mebendazole | P,S,T | Tablet 100 mg | |
| Oral liquid 100 mg/5 ml | ||||
| 6.1.2–Antifilarial | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Diethylcarbamazin | Tablet 50 mg | |||
| 6.1.2.1 | P,S,T | Tablet 100 mg | ||
| e | ||||
| Oral liquid 120 mg/5 ml | ||||
| 6.1.3–Anti-schistosomal & anti-trematodal medicine | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 6.1.3.1 | Praziquantel | S,T | Tablet 600 mg | |
| 6.2–Antibacterials | ||||
| 6.2.1–Beta lactam medicines | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Capsule 250 mg | ||||
| 6.2.1.1 | Amoxicillin | P,S,T | Capsule 500 mg | |
| Oral liquid 250 mg/5 ml | ||||
| Tablet 500 mg (A) + 125 mg (B) | ||||
| Amoxicillin (A) + | Oral liquid 200 mg (A) + 28.5 mg | |||
| 6.2.1.2 | P,S,T | (B)/5 ml | ||
| Clavulanic acid (B) | ||||
| Dry Syrup 125 mg (A) + 31.25 | ||||
| (B)/5 ml | ||||
| Powder for Injection 500 mg (A) + | ||||
| S,T | 100 mg (B) | |||
| Powder for Injection 1 g (A) + 200 | ||||
| mg (B) | ||||
| 6.2.1.3 | Ampicillin | P,S,T | Powder for Injection 500 mg | |
| Powder for Injection 1 g | ||||
| 6.2.1.4 | Benzathine | P,S,T | Powder for Injection 6 lac units | |
| benzylpenicillin | Powder for Injection 12 lac units | |||
| 6.2.1.5 | Benzyl penicillin | P,S,T | Powder for Injection 10 lac units | |
| Tablet 500 mg | ||||
| 6.2.1.6 | Cefadroxil | P,S,T | Tablet 1 g | |
| Oral liquid 125 mg/5 ml | ||||
| 6.2.1.7 | Cefazolin | P,S,T | Powder for Injection 500 mg | |
| Powder for Injection 1 g | ||||
| Tablet 200 mg | ||||
| 6.2.1.8 | Cefixime | S,T | Tablet 400 mg | |
| Oral liquid 50 mg/5 ml | ||||
| Oral liquid 100 mg/5 ml | ||||
| Powder for Injection 250 mg | ||||
| 6.2.1.9 | Cefotaxime | S,T | Powder for Injection 500 mg | |
| Powder for Injection 1 g | ||||
| 6.2.1.1 | Ceftazidime | S,T | Powder for Injection 250 mg | |
| 0 | Powder for Injection 1 g | |||
| Powder for Injection 250 mg | ||||
| 6.2.1.1 | Ceftriaxone | S,T | Powder for Injection 500 mg | |
| 1 | Powder for Injection 1 g | |||
| Powder for Injection 2 g | ||||
| Capsule 250 mg | ||||
| 6.2.1.1 | Cloxacillin | P,S,T | Capsule 500 mg | |
| 2 | Oral Liquid 125 mg/5 ml | |||
| Powder for Injection 250 mg | ||||
| Powder for Injection 1 g (A) + 125 | ||||
| mg (B) | ||||
| 6.2.1.1 | Piperacillin (A) + | T | Powder for Injection 2 g (A) + 250 | |
| 3 | Tazobactam (B) | mg (B) | ||
| Powder for Injection 4 g (A) + 500 | ||||
| mg (B) | ||||
| 6.2.2–Other antibacterials | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Tablet 250 mg | ||||
| 6.2.2.1 | Azithromycin | P,S,T | Tablet 500 mg | |
| Oral liquid 200 mg/5ml | ||||
| Powder for Injection 500 mg | ||||
| Tablet 250 mg | ||||
| 6.2.2.2 | Ciprofloxacin | P,S,T | Tablet 500 mg | |
| Oral liquid 250 mg/5ml | ||||
| Injection 200 mg/100 ml | ||||
| Tablet 250 mg | ||||
| 6.2.2.3 | Clarithromycin | S,T | Tablet 500 mg | |
| Oral liquid 125mg/5 ml | ||||
| Co-trimoxazole | Tablet 400 mg (A) + 80 mg (B) | |||
| 6.2.2.4 | [Sulphamethoxazol | P,S,T | Tablet 800 mg (A) + 160 mg (B) | |
| e (A) + | Oral liquid 200 mg (A) + 40 mg | |||
| Trimethoprim (B)] | (B)/5 ml | |||
| 6.2.2.5 | Doxycycline | P,S,T | Capsule 100 mg | |
| Dry Syrup 50mg/5 ml | ||||
| 6.2.2.6 | Gentamicin | P,S,T | Injection 10 mg/ml | |
| Injection 40 mg/ml | ||||
| Tablet 200 mg | ||||
| 6.2.2.7 | Metronidazole | P,S,T | Tablet 400 mg | |
| Oral liquid 200 mg/5 ml | ||||
| Injection 500 mg/100 ml | ||||
| 6.2.2.8 | Nitrofurantoin | P,S,T | Tablet 100 mg | |
| Oral liquid 25 mg/5 ml | ||||
| Powder for Injection 250 mg | ||||
| 6.2.2.9 | Vancomycin | T | Powder for Injection 500 mg | |
| Powder for Injection 1 g | ||||
| 6.2.3–Antileprosy medicines | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 6.2.3.1 | Clofazimine | P,S,T | Capsule 50 mg | |
| Capsule 100 mg | ||||
| Tablet 25 mg | ||||
| 6.2.3.2 | Dapsone | P,S,T | Tablet 50 mg | |
| Tablet 100 mg | ||||
| 6.2.3.3 | Rifampicin | P,S,T | Capsule 150 mg | |
| Capsule 300 mg | ||||
| 6.2.4–Antituberculosis medicines | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 6.2.4.1 | Capreomycin | P,S,T | Powder for Injection 1 g | |
| 6.2.4.2 | Cycloserine | P,S,T | Capsule 125 mg | |
| Capsule 250 mg | ||||
| Tablet 200 mg | ||||
| 6.2.4.3 | Ethambutol | P,S,T | Tablet 400 mg | |
| Tablet 600 mg | ||||
| Tablet 800 mg | ||||
| 6.2.4.4 | Ethionamide | P,S,T | Tablet 125 mg | |
| Tablet 250 mg | ||||
| Tablet 50 mg | ||||
| 6.2.4.5 | Isoniazid | P,S,T | Tablet 100 mg | |
| Tablet 300 mg | ||||
| Oral liquid 100 mg/5 ml | ||||
| Powder for Injection 500 mg | ||||
| 6.2.4.6 | Kanamycin | P,S,T | Powder for Injection 750 mg | |
| Powder for Injection 1 g | ||||
| Tablet 250 mg | ||||
| 6.2.4.7 | Levofloxacin | P,S,T | Tablet 500 mg | |
| Tablet 750 mg | ||||
| 6.2.4.8 | Linezolid | P,S,T | Tablet 600 mg | |
| 6.2.4.9 | Moxifloxacin | P,S,T | Tablet 200 mg | |
| Tablet 400 mg | ||||
| 6.2.4.1 | Para- | P,S,T | Tablet 500 mg | |
| 0 | aminosalicylic acid | Granules (As licensed) | ||
| Tablet 500 mg | ||||
| 6.2.4.1 | Tablet 750 mg | |||
| Pyrazinamide | P,S,T | Tablet 1000 mg | ||
| 1 | ||||
| Tablet 1500 mg | ||||
| Oral liquid 250 mg/5 ml | ||||
| 6.2.4.1 | Rifabutin | S,T | Capsule 150 mg | |
| 2 | ||||
| Page 18 of 117 | ||||
| Capsule 150 mg | ||||
| 6.2.4.1 | Capsule 300 mg | |||
| Rifampicin | P,S,T | Capsule 450 mg | ||
| 3 | ||||
| Capsule 600 mg | ||||
| Oral liquid 100 mg/5 ml | ||||
| 6.2.4.1 | Streptomycin | P,S,T | Powder for Injection 750 mg | |
| 4 | Powder for Injection 1 g | |||
| 6.3–Antifungal medicines | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Amphotericin B | ||||
| a) Amphotericin B | ||||
| 6.3.1 | (conventional) | S,T | Powder for Injection 50 mg | |
| b) Lipid/ | ||||
| Liposomal | ||||
| Amphotericin B | ||||
| 6.3.2 | Clotrimazole | P,S,T | Pessary 100 mg | |
| Tablet 100 mgTablet 150 mgTablet | ||||
| 6.3.3 | Fluconazole | P,S,T | 200 mgTablet 400 mgOral liquid 50 | |
| mg/5 ml | ||||
| S,T | Injection 200 mg /100 ml | |||
| Tablet 125 mg | ||||
| 6.3.4 | Griseofulvin | P,S,T | Tablet 250 mg | |
| Tablet 375 mg | ||||
| Page 19 of 117 | ||||
| Tablet 500,000 IU | ||||
| 6.3.5 | Nystatin | P,S,T | Pessary 100,000 IU | |
| Oral Liquid 100, 000 IU/ml | ||||
| 6.4–Antiviral medicines | ||||
| 6.4.1–Antiherpes medicines | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Tablet 200 mg | ||||
| Tablet 400 mg | ||||
| 6.4.1.1 | Acyclovir | P,S,T | Powder for Injection 250 mg | |
| Powder for Injection 500 mg | ||||
| Oral liquid 400 mg/5 ml | ||||
| 6.4.2–Anti Cytomegalovirus (CMV) medicines | ||||
| 6.4.2.1 | Ganciclovir | S,T | Capsule 250 mg | |
| Powder for Injection 500 mg | ||||
6.4.3–Antiretroviral medicines
6.4.3.1–Nucleoside reverse transcriptase inhibitors
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 6.4.3.1 | Abacavir | S,T | Tablet 60 mg | |
| .1 | Tablet 300 mg | |||
| 6.4.3.1 | Abacavir (A) + | S,T | Tablet 60 mg (A) +30 mg (B) | |
| .2 | Lamivudine (B) | Tablet 600 mg (A)+ 300 mg (B) | ||
| Lamivudine (A) + | Dispersible Tablet 30 mg (A) + 50 | |||
| 6.4.3.1 | mg (B) + 6 mg (C) | |||
| Nevirapine (B) + | S,T | |||
| .3 | Tablet 150 mg (A) + 200 mg (B) + | |||
| Stavudine (C) | ||||
| 30 mg (C) | ||||
| 6.4.3.1 | Lamivudine (A) + | S,T | Tablet 30 mg (A) + 60 mg (B) | |
| .4 | Zidovudine (B) | Tablet 150 mg (A) + 300 mg (B) | ||
| 6.4.3.1 | Stavudine (A) + | Dispersible Tablet 6 mg (A) + 30 | ||
| S,T | mg (B) | |||
| .5 | Lamivudine (B) | |||
| Tablet 30 mg (A) + 150 mg (B) | ||||
| 6.4.3.1 | Tenofovir (A) + | S,T | Tablet 300 mg (A) +300 mg (B) | |
| .6 | Lamivudine (B) | |||
| 6.4.3.1 | Tenofovir (A) + | Tablet 300 mg (A) + 300 mg (B) + | ||
| Lamivudine (B) + | S,T | |||
| .7 | 600 mg (C) | |||
| Efavirenz (C) | ||||
| 6.4.3.1 | Zidovudine | S,T | Tablet 300 mg | |
| .8 | Oral liquid 50 mg/5 ml | |||
| Zidovudine (A) + | Tablet 60 mg (A) + 30 mg (B) + 50 | |||
| 6.4.3.1 | mg (C) | |||
| Lamivudine (B) + | S,T | |||
| .9 | Tablet 300 mg (A) + 150 mg (B) + | |||
| Nevirapine (C) | ||||
| 200 mg (C) | ||||
6.4.3.2–Non-nucleoside reverse transcriptase inhibitors
| Medicine | Level of | Dosage form and strength | |||||
| Healthcare | |||||||
| 6.4.3.2 | Tablet 50 mg | ||||||
| Efavirenz | S,T | Tablet 200 mg | |||||
| .1 | |||||||
| Tablet 600 mg | |||||||
| 6.4.3.2 | Dispersible Tablet 50 mg | ||||||
| Nevirapine | S,T | Tablet 200 mg | |||||
| .2 | |||||||
| Oral liquid 50 mg/5 ml | |||||||
| 6.4.3.3–Integrase inhibitors | |||||||
| 6.4.3.3.1 | Raltegravir | S,T | Tablet 400 mg | ||||
| 6.4.3.4–Protease inhibitors | |||||||
| Level of | |||||||
| Medicine | Healthcare Dosage form and strength | ||||||
| 6.4.3.4.1 | Atazanavir (A) + | S,T | Tablet 300 mg (A) + 100 mg (B) | ||||
| Ritonavir (B) | |||||||
| 6.4.3.4.2 Darunavir | S,T | Tablet 600 mg |
| Tablet 100 mg (A) + 25 mg (B) | ||||
| 6.4.3.4.3 | Lopinavir (A) + | S,T | Tablet 200 mg (A) + 50 mg (B) | |
| Ritonavir (B) | Oral liquid 400 mg (A) + 100 mg | |||
| (B)/ 5ml | ||||
Page 22 of 117
| 6.4.3.4.4 | Ritonavir | S,T | Tablet 100 mg | |
| 6.4.4–Medicines for hepatitis B and hepatitis C | ||||
| 6.4.4.1 | Entecavir | S,T | Tablet 0.5 mg | |
| Tablet 1 mg | ||||
| 6.4.4.2 | Pegylated | S,T | Injection 180 mcg | |
| interferon alfa 2a | ||||
| Pegylated | Injection 80 mcg | |||
| S,T | Injection 100 mcg | |||
| interferon alfa 2b | ||||
| Injection 120 mcg | ||||
| 6.4.4.3 | Ribavirin | S,T | Capsule 200 mg | |
| 6.4.4.4 | Sofosbuvir | S,T | Tablet 400 mg | |
| 6.4.4.5 | Tenofovir | S,T | Tablet 300 mg | |
Section 6.5–Antiprotozoal Medicines
6.5.1–Antiamoebic and antigiardiasis medicines
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 6.5.1.1 | Diloxanide furoate | P,S,T | Tablet 500 mg | |
| Tablet 200 mg | ||||
| 6.5.1.2 | Metronidazole | P,S,T | Tablet 400 mg | |
| Injection 500 mg/100 ml | ||||
| Oral liquid 200 mg/5 ml | ||||
6.5.2–Antileishmaniasis medicines
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Amphotericin B | ||||
| a) Amphotericin B | ||||
| 6.5.2.1 | (conventional) | S,T | Powder for Injection 50 mg | |
| b) Lipid/ | ||||
| Liposomal | ||||
| Amphotericin B | ||||
| 6.5.2.2 Miltefosine | P,S,T | Capsule 10 mg | ||
| Capsule 50 mg\ | ||||
| 6.5.2.3 Paromomycin | P,S,T | Injection 375 mg/ml |
| 6.5.3–Antimalarial medicines | ||||
| 6.5.3.1–For curative treatment | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Tablet 20 mg (A) + 120 mg (B) | ||||
| 6.5.3.1 | Artemether (A) + | Tablet 40 mg (A) + 240 mg (B) | ||
| P,S,T | Tablet 80 mg (A) + 480 mg (B) | |||
| .1 | Lumefantrine (B) | |||
| Oral liquid 80 mg (A) + 480 mg | ||||
| (B)/5 ml | ||||
| 6.5.3.1 | Artesunate | P,S,T | Powder for Injection 60 mg | |
| .2 | Powder for Injection 120 mg | |||
| Combi pack (A+B) | ||||
| 1 Tablet 25 mg (A) + 1 Tablet | ||||
| (250 mg + 12.5 mg) (B) | ||||
| 1 Tablet 50 mg (A) + 1 Tablet | ||||
| 6.5.3.1 | Artesunate (A) + | (500 mg + 25 mg) (B) | ||
| Sulphadoxine – | P,S,T | 1 Tablet 100 mg (A) + 1 Tablet | ||
| .3 | ||||
| Pyrimethamine (B) | (750 mg + 37.5 mg) (B) | |||
| 1 Tablet 150 mg (A) + 2 Tablet | ||||
| (500 mg + 25 mg) (B) | ||||
| 1 Tablet 200 mg (A) + 2 Tablet | ||||
| (750 mg + 37.5 mg) (B) | ||||
| 6.5.3.1 | Chloroquine | P,S,T | Tablet 150 mg | |
| .4 | Oral liquid 50 mg/5 ml | |||
| 6.5.3.1 | Clindamycin | P,S,T | Capsule 150 mg | |
| .5 | Capsule 300 mg | |||
Page 25 of 117
| 6.5.3.1 | Tablet 2.5 mg | |||
| Primaquine | P,S,T | Tablet 7.5 mg | ||
| .6 | ||||
| Tablet 15 mg | ||||
| 6.5.3.1 | Quinine | P,S,T | Tablet 300 mg | |
| .7 | Injection 300 mg/ml | |||
| 6.5.3.2–For prophylaxis | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Tablet 250 mg | ||||
| 6.5.3.2 | *Only for use as chemoprophylaxis | |||
| Mefloquine | T | for long term travellers like military | ||
| .1 | ||||
| and travel troops, travelling from | ||||
| low endemic to high endemic area. | ||||
| 6.5.4–Antipneumocystosis and antitoxoplasmosis medicines | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Co-trimoxazole | Tablet 400 mg (A) + 80 mg (B) | |||
| 6.5.4.1 | [Sulphamethoxazol | P,S,T | Tablet 800 mg (A) + 160 mg (B) | |
| e (A) + | Oral liquid 200 mg (A) + 40 mg | |||
| Trimethoprim (B)] | (B)/5 ml | |||
| 6.5.4.2 Pentamidine | S,T | Powder for Injection 200 mg |
Section 7–Antimigraine medicines
| Medicine | Level of | Dosage form and strength | |||||
| Healthcare | |||||||
| Acetylsalicylic | Tablet 300 mg to 500 mg | ||||||
| 7.1.1 | P,S,T | Effervescent/ Dispersible/ Enteric | |||||
| acid | |||||||
| coated Tablet 300 mg to 500 mg | |||||||
| 7.1.2 | Paracetamol | P,S,T | Tablet 500 mg | ||||
| Tablet 650 mg | |||||||
| Tablet 25 mg | |||||||
| 7.1.3 | Sumatriptan | P,S,T | Tablet 50 mg | ||||
| Injection 6 mg/ 0.5 ml | |||||||
| 7.2–For prophylaxis | |||||||
| Medicine | Level of | Dosage form and strength | |||||
| Healthcare | |||||||
| 7.2.1 | Flunarizine | P,S,T | Tablet 5 mg | ||||
| Tablet 10 mg | |||||||
| Tablet 10 mg | |||||||
| 7.2.2 | Propranolol | P,S,T | Tablet 40 mg | ||||
| Tablet 80 mg | |||||||
Section 8 –Antineoplastic/ immunosuppressives and medicines used in palliative care
8.1–Antineoplastic medicines
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 8.1.1 | 5-Fluorouracil | T | Injection 250 mg/5 ml | |
| 8.1.2 | 6-Mercaptopurine | T | Tablet 50 mg | |
| 8.1.3 | Actinomycin D | T | Powder for Injection 0.5 mg | |
| 8.1.4 | All-trans retinoic | T | Capsule 10 mg | |
| acid | ||||
| 8.1.5 | Arsenic trioxide | T | Injection 1mg/ml | |
| 8.1.6 | Bleomycin | T | Powder for Injection 15 units | |
| 8.1.7 | Bortezomib | T | Powder for Injection 2mg | |
| 8.1.8 | Calcium folinate | T | Tablet 15 mg | |
| Injection 3 mg/ml | ||||
| 8.1.9 | Capecitabine | T | Tablet 500 mg | |
Page 28 of 117
| 8.1.10 | Carboplatin | T | Injection 10 mg/ml | |
| 8.1.11 | Chlorambucil | T | Tablet 2 mg | |
| Tablet 5 mg | ||||
| 8.1.12 | Cisplatin | T | Injection 1mg/ml | |
| Tablet 50 mg | ||||
| 8.1.13 | Cyclophosphamide | T | Tablet 200 mg | |
| Powder for Injection 500 mg | ||||
| Cytosine | Injection 100 mg/ ml | |||
| 8.1.14 | T | Powder for Injection 500 mg | ||
| arabinoside | ||||
| Powder for Injection 1000 mg | ||||
| 8.1.15 | Dacarbazine | T | Powder for Injection 500 mg | |
| Powder for Injection 200 mg | ||||
| 8.1.16 | Daunorubicin | T | Injection 5 mg/ml | |
| 8.1.17 | Docetaxel | T | Powder for Injection 20 mg | |
| Powder for Injection 80 mg | ||||
| 8.1.18 | Doxorubicin | T | Injection 2 mg/ml | |
| Capsule 50 mg | ||||
| 8.1.19 | Etoposide | T | Capsule 100 mg | |
| Injection 20 mg/ml | ||||
| 8.1.20 | Gefitinib | T | Tablet 250 mg | |
| 8.1.21 | Gemcitabine | T | Powder for Injection 200 mg | |
| Powder for Injection 1 g | ||||
| 8.1.22 | Ifosfamide | T | Powder for Injection 1 g | |
| Powder for Injection 2 g | ||||
| 8.1.23 | Imatinib | T | Tablet 100 mg | |
| Tablet 400 mg | ||||
| 8.1.24 | L-Asparaginase | T | Powder for Injection 5000 KU. | |
| Powder for Injection 10000 KU | ||||
| 8.1.25 | Melphalan | T | Tablet 2 mg | |
| Tablet 5 mg | ||||
| 8.1.26 | Mesna | T | Injection 100 mg/ml | |
| Tablet 2.5 mg | ||||
| 8.1.27 | Methotrexate | T | Tablet 5 mg | |
| Tablet 10mg | ||||
| Injection 50 mg/ml | ||||
| 8.1.28 | Oxaliplatin | T | Injection 5 mg/ml | |
| 8.1.29 | Paclitaxel | T | Injection 30 mg/5 ml | |
| Injection 100 mg/16.7 ml | ||||
| Page 30 of 117 | ||||
| 8.1.30 | Procarbazine | T | Capsule 50 mg | |
| 8.1.31 | Rituximab | T | Injection 10 mg/ml | |
| Capsule 20 mg | ||||
| 8.1.32 | Temozolomide | T | Capsule 100 mg | |
| Capsule 250 mg | ||||
| 8.1.33 | Thalidomide | T | Capsule 50 mg | |
| Capsule 100 mg | ||||
| 8.1.34 | Trastuzumab | T | Injection 440 mg/50 ml | |
| 8.1.35 | Vinblastine | T | Injection 1 mg/ml | |
| 8.1.36 | Vincristine | T | Injection 1 mg/ml | |
| 8.2–Hormones and antihormones used in cancer therapy | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 8.2.1 | Bicalutamide | T | Tablet 50 mg | |
Page 31 of 117
| 8.2.2 | Letrozole | T | Tablet 2.5 mg | |
| Tablet 10 mg | ||||
| Tablet 20 mg | ||||
| 8.2.3 | Prednisolone | S, T | Tablet 40 mg | |
| Oral liquid 5 mg/5 ml | ||||
| Oral liquid 15 mg/5 ml | ||||
| Injection 20 mg/2 ml | ||||
| 8.2.4 | Tamoxifen | T | Tablet 10 mg | |
| Tablet 20 mg | ||||
| 8.3–Immunosuppressive medicines | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 8.3.1 | Azathioprine | T | Tablet 50 mg | |
| Capsule10 mg | ||||
| Capsule 25 mg | ||||
| 8.3.2 | Cyclosporine | T | Capsule 50 mg | |
| Capsule 100 mg | ||||
| Oral liquid 100 mg/ml | ||||
| Injection 50 mg/ml | ||||
| 8.3.3 | Mycophenolate | T | Tablet 250 mg | |
| mofetil | Tablet 500 mg | |||
| Capsule 0.5 mg | ||||
| 8.3.4 | Tacrolimus | T | Capsule 1 mg | |
| Capsule 2 mg | ||||
| Page 32 of 117 | ||||
| 8.4–Medicines used in palliative care | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 8.4.1 | Allopurinol | T | Tablet 100 mg | |
| 8.4.2 | Amitriptyline | T | Tablet 10 mg | |
| Tablet 25 mg | ||||
| 8.4.3 | Dexamethasone | T | Tablet 0.5 mg | |
| Injection 4 mg/ml | ||||
| Tablet 2 mg | ||||
| 8.4.4 | Diazepam | T | Tablet 5 mg | |
| Injection 5 mg/ml | ||||
| 8.4.5 | Filgrastim | T | Injection 300 mcg | |
| 8.4.6 | Fluoxetine | T | Capsule 20 mg | |
| Tablet 1.5 mg | ||||
| 8.4.7 | Haloperidol | T | Tablet 5 mg | |
| Injection 5 mg/ml | ||||
| 8.4.8 | Lactulose | T | Oral liquid 10 g/15 ml | |
| 8.4.9 | Loperamide | T | Tablet 2 mg | |
| Tablet 10 mg | ||||
| 8.4.10 | Metoclopramide | T | Oral liquid 5 mg/5 ml | |
| Injection 5 mg/ml | ||||
| 8.4.11 | Midazolam | T | Injection 1 mg/ml | |
| Tablet 10 mg | ||||
| 8.4.12 | Morphine | T | Tablet 20 mg | |
| SR Tablet 30 mg | ||||
| Tablet 4 mg | ||||
| 8.4.13 | Ondansetron | S,T | Tablet 8 mg | |
| Oral liquid 2 mg/5 ml | ||||
| Injection 2 mg/ml | ||||
| Capsule 50 mg | ||||
| 8.4.14 | Tramadol | T | Capsule 100 mg | |
| Injection 50 mg/ml | ||||
| 8.4.15 | Zoledronic acid | T | Powder for Injection 4 mg | |
Page 34 of 117
Section 9–Antiparkinsonism medicines
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Tablet 100 mg (A) + 10 mg (B) | ||||
| Tablet 100 mg (A) + 25 mg (B) | ||||
| Levodopa (A) + | CR Tablet 100 mg (A) + 25 mg | |||
| 9.1 | P,S,T | (B) | ||
| Carbidopa (B) | ||||
| CR Tablet 200 mg (A) + 50 (B) | ||||
| mg | ||||
| Tablet 250 mg (A) + 25 mg (B) | ||||
| 9.2 | Trihexyphenidyl | P,S,T | Tablet 2 mg | |
| Section 10–Medicines affecting blood | ||||
| 10.1–Antianaemia medicines | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 10.1.1 | Erythropoietin | S,T | Injection 2000 IU/ml | |
| Injection 10000 IU/ml | ||||
| Tablet equivalent to 60 mg of | ||||
| 10.1.2 | Ferrous salts | P,S,T | elemental iron | |
| Oral liquid equivalent to 25 mg of | ||||
| elemental iron/ml | ||||
| Tablet 45mg elemental iron (A) + | ||||
| 400 mcg (B) | ||||
| 10.1.3 | Ferrous salt (A) + | P,S,T | Tablet 100 mg elemental iron (A) | |
| Folic acid (B) | + 500 mcg (B) | |||
| Oral liqiud 20 mg elemental iron | ||||
| (A) + 100 mcg (B)/ml | ||||
Page 35 of 117
| 10.1.4 | Folic acid | P,S,T | Tablet 5 mg | |
| 10.1.5 | Hydroxocobalamin | P,S,T | Injection 1 mg/ml | |
| 10.1.6 | Hydroxyurea | P,S,T | Capsule 500 mg | |
| 10.1.7 | Iron sucrose | S,T | Injection 20 mg/ml | |
| 10.2–Medicines affecting coagulation | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 10.2.1 | Enoxaparin | T | Injection 40 mg/0.4 ml | |
| Injection 60 mg/0.6 ml | ||||
| 10.2.2 | Heparin | S,T | Injection 1000 IU/ml | |
| Injection 5000 IU/ml | ||||
| 10.2.3 | Phytomenadione | P,S,T | Tablet 10mg | |
| (Vitamin K1) | Injection 10 mg/ml | |||
| 10.2.4 | Protamine | S,T | Injection 10 mg/ml | |
Page 36 of 117
| 10.2.5 | Tranexamic acid | P,S,T | Tablet 500 mg | |
| Injection 100 mg/ml | ||||
| Tablet 1mg | ||||
| 10.2.6 | Warfarin | S,T | Tablet 2 mg | |
| Tablet 3 mg | ||||
| Tablet 5 mg | ||||
| Section 11–Blood products and Plasma substitutes | ||||
11.1–Blood and Blood components
All forms of the following as approved by licensing authority are considered as included in NLEM. However, considering the process, technology and other relevant aspects, they should be considered differently for purposes such as procurement policy, pricing etc.
| 11.1.1 | Fresh frozen | S,T | As licensed | |
| plasma | ||||
| 11.1.2 | Platelet rich | S,T | As licensed | |
| plasma | ||||
| 11.1.3 | Red blood cells | S,T | As licensed | |
| 11.1.4 | Whole blood | S,T | As licensed | |
11.2–Plasma substitutes
| Medicine | Level of | Dosage form and strength | |
| Healthcare | |||
| 11.2.1 | Dextran-40 | S,T | Injection 10% |
11.3–Plasma fractions for specific use
In case of coagulation factors and other blood products, irrespective of variation in source, all forms of these products as approved by licensing authority are considered as included in NLEM. However, considering the source, process, technology and other relevant aspects, they should be considered differently for purposes such as procurement policy, pricing etc.
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 11.3.1 | Coagulation factor | S,T | Powder for Injection 600 IU | |
| IX | ||||
| 11.3.2 | Coagulation factor | S,T | Powder for Injection 250 IU | |
| VIII | Powder for Injection 500 IU | |||
| 11.3.3 | Cryoprecipitate | S,T | As licensed | |
Page 38 of 117
Section 12–Cardiovascular medicines
12.1–Medicines used in angina
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Tablet 75 mg | ||||
| Effervescent/ Dispersible/ Enteric | ||||
| coated Tablet 75 mg | ||||
| Acetylsalicylic | Tablet 100 mg | |||
| 12.1.1 | P,S,T | Effervescent/ Dispersible/ Enteric | ||
| acid | ||||
| coated Tablet 100 mg | ||||
| Tablet 150 mg | ||||
| Effervescent/ Dispersible/ Enteric | ||||
| coated Tablet 150 mg |
| 12.1.2 | Clopidogrel | P,S,T | Tablet 75 mg |
| Tablet 30 mg | ||||
| 12.1.3 | Diltiazem | P,S,T | Tablet 60 mg | |
| SR Tablet 90 mg | ||||
| T | Injection 5 mg/ml | |||
| 12.1.4 | Glyceryl trinitrate | P,S,T | Sublingual tablet 0.5 mg | |
| S,T | Injection 5 mg/ml | |||
| Tablet 10 mg | ||||
| 12.1.5 | Isosorbide-5- | P,S,T | Tablet 20 mg | |
| mononitrate | SR Tablet 30 mg | |||
| SR Tablet 60 mg | ||||
| 12.1.6 | Isosorbide dinitrate | P,S,T | Tablet 5 mg | |
| Tablet 10 mg | ||||
Page 39 of 117
| Tablet 25 mg | ||||
| 12.1.7 | Metoprolol | P,S,T | Tablet 50 mg | |
| SR Tablet 25 mg | ||||
| SR Tablet 50 mg | ||||
| 12.2–Antiarrhythmic medicines | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 12.2.1 | Adenosine | S,T | Injection 3 mg/ml | |
| Tablet 100 mg | ||||
| 12.2.2 | Amiodarone | S,T | Tablet 200 mg | |
| Injection 50 mg/ml | ||||
| 12.2.3 | Esmolol | T | Injection 10 mg/ml | |
| 12.2.4 | Lignocaine | S,T | Injection 2% (Preservative free for | |
| IV use) | ||||
| Tablet 40 mg | ||||
| 12.2.5 | Verapamil | S,T | Tablet 80 mg | |
| Injection 2.5 mg/ml | ||||
| 12.3–Antihypertensive medicines | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Tablet 2.5 mg | ||||
| 12.3.1 | Amlodipine | P,S,T | Tablet 5 mg | |
| Tablet 10 mg | ||||
| Page 40 of 117 | ||||
| 12.3.2 | Atenolol | P,S,T | Tablet 50 mg | |
| Tablet 100 mg | ||||
| 12.3.3 | Enalapril | P,S,T | Tablet 2.5 mg | |
| Tablet 5 mg | ||||
| 12.3.4 | Hydrochlorothiazid | P,S,T | Tablet 12.5 mg | |
| e | Tablet 25 mg | |||
| 12.3.5 | Labetalol | P,S,T | Injection 5 mg/ml | |
| 12.3.6 | Methyldopa | P,S,T | Tablet 250 mg | |
| Tablet 500 mg | ||||
| 12.3.7 | Ramipril | P,S,T | Tablet 2.5 mg | |
| Tablet 5 mg | ||||
| 12.3.8 | Sodium | T | Injection 10 mg/ml | |
| nitroprusside | ||||
| Tablet 20 mg | ||||
| 12.3.9 | Telmisartan | P,S,T | Tablet 40 mg | |
| Tablet 80 mg | ||||
Page 41 of 117
12.4–Medicines used in shock and heart failure
| Medicine | Level of | Dosage form and strength | |
| Healthcare | |||
| Tablet 0.25 mg | |||
| 12.4.1 | Digoxin | S,T | Oral liquid 0.05 mg/ml |
| Injection 0.25 mg/ml |
| 12.4.2 | Dobutamine | S,T | Injection 50 mg/ml |
| 12.4.3 | Dopamine | S,T | Injection 40 mg/ml |
| 12.4.4 | Noradrenaline | S,T | Injection 2 mg/ml |
12.5–Antithrombotic medicine (Cardiovascular/ Cerebrovascular)
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Tablet 75 mg | ||||
| Effervescent/ Dispersible/ Enteric | ||||
| coated Tablet 75 mg | ||||
| Acetylsalicylic | Tablet 100 mg | |||
| 12.5.1 | P,S,T | Effervescent/ Dispersible/ Enteric | ||
| acid | ||||
| coated Tablet 100 mg | ||||
| Tablet 150 mg | ||||
| Effervescent/ Dispersible/ Enteric | ||||
| coated Tablet 150 mg | ||||
Page 42 of 117
| 12.5.2 | Alteplase | T | Powder for Injection 20 mg | |
| Powder for Injection 50 mg | ||||
| 12.5.3 | Heparin | S,T | Injection 1000 IU/ml | |
| Injection 5000 IU/ml | ||||
| 12.5.4 | Streptokinase | S,T | Injection 750,000 IU Injection | |
| 15,00,000 IU | ||||
| 12.6–Hypolipidemic medicines | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Tablet 10 mg | ||||
| 12.6.1 | Atorvastatin | P,S,T | Tablet 20 mg | |
| Tablet 40 mg | ||||
| Section 13–Medicines used in dementia | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 13.1 | Donepezil | S,T | Tablet 5 mg | |
| Tablet 10 mg | ||||
| Section 14–Dermatological medicines (Topical) | ||||
| 14.1–Antifungal medicines | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 14.1.1 | Clotrimazole | P,S,T | Cream 1% | |
Page 43 of 117
14.2–Antiinfective medicines
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 14.2.1 | Framycetin | P,S,T | Cream 0.5% | |
| 14.2.2 | Fusidic acid | P,S,T | Cream 2% | |
| Methylrosaniliniu | ||||
| 14.2.3 | m chloride | P,S,T | Topial preparation 0.25% to 2% | |
| (Gentian Violet) | ||||
| 14.2.4 | Povidone iodine | P,S,T | Solution 4% to 10% | |
| 14.2.5 | Silver | P,S,T | Cream 1% | |
| sulphadiazine | ||||
| 14.3–Antiinflammatory and antipruritic medicines | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 14.3.1 | Betamethasone | P,S,T | Cream 0.05% | |
| Cream 0.1% | ||||
| 14.3.2 | Calamine | P,S,T | Lotion (As per IP) | |
Page 44 of 117
14.4–Medicines affecting skin differentiation and proliferation
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 14.4.1 | Benzoyl peroxide | P,S,T | Gel 2.5% | |
| 14.4.2 | Coal tar | P,S,T | Solution 5% | |
| 14.4.3 | Podophyllin resin | S,T | Solution 10% to 25% | |
| 14.4.4 | Salicylic acid | P,S,T | Ointment 6% | |
| 14.5–Scabicides and pediculicides | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 14.5.1 | Permethrin | P,S,T | Lotion 1% | |
| Cream 5% | ||||
| 14.6–Miscellaneous | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 14.6.1 | Glycerin | P,S,T | Oral Liquid | |
| 14.6.2 | White Petrolatum | P,S,T | Jelly 100% | |
Page 45 of 117
| Section 15 –Diagnostic agents | ||||
| 15.1–Ophthalmic medicines | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 15.1.1 | Fluorescein | S,T | Eye drop 1% | |
| 15.1.2 | Lignocaine | S,T | Eye drop 4% | |
| 15.1.3 | Tropicamide | S,T | Eye drop 1% | |
| 15.2–Radiocontrast media | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 15.2.1 | Barium sulphate | S,T | Oral liquid 100% w/v | |
| Oral liquid 250% w/v | ||||
| 15.2.2 | Gadobenate | T | Injection 529 mg/ml | |
| 15.2.3 | Iohexol | S,T | Injection 140 to 350 mg iodine/ml | |
| 15.2.4 | Meglumine | S,T | Injection 60% w/v | |
| diatrizoate | Injection 76% w/v | |||
Page 46 of 117
Section 16–Dialysis solutions
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 16.1 | Haemodialysis | S,T | As licensed | |
| fluid | ||||
| 16.2 | Intraperitoneal | S,T | As licensed | |
| dialysis solution | ||||
| Section 17–Disinfectants and antiseptics | ||||
| 17.1–Antiseptics | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 17.1.1 | Cetrimide | P,S,T | Solution 20% (Concentrate for | |
| dilution) | ||||
| 17.1.2 | Chlorhexidine | P,S,T | Solution 5% (Concentrate for | |
| dilution) | ||||
| 17.1.3 | Ethyl alcohol | P,S,T | Solution 70% | |
| (Denatured) | ||||
| 17.1.4 | Hydrogen peroxide | P,S,T | Solution 6% | |
| Methylrosaniliniu | ||||
| 17.1.5 | m chloride | P,S,T | Topial preparation 0.25% to 2% | |
| (Gentian Violet) | ||||
| 17.1.6 | Povidone iodine | P,S,T | Solution 4% to 10% | |
Page 47 of 117
17.2–Disinfectants
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 17.2.1 | Bleaching powder | P,S,T | Containing not less than 30% w/w | |
| of available chlorine (as per I.P) | ||||
| 17.2.2 | Glutaraldehyde | S,T | Solution 2% | |
| 17.2.3 | Potassium | P,S,T | Crystals for topical solution | |
| permanganate | ||||
| Section 18–Diuretics | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Tablet 40 mg | ||||
| 18.1 | Furosemide | P,S,T | Oral liquid 10 mg/ml | |
| Injection 10 mg/ ml | ||||
| 18.2 | Hydrochlorothiazid | P,S,T | Tablet 25 mg | |
| e | Tablet 50 mg | |||
| 18.3 | Mannitol | P,S,T | Injection 10% | |
| Injection 20% | ||||
| 18.4 | Spironolactone | P,S,T | Tablet 25 mg | |
| Tablet 50 mg | ||||
Page 48 of 117
Section 19–Ear, nose and throat medicines
| 19.1 | Budesonide | P,S,T | Nasal Spray 50 mcg/dose | |
| Nasal Spray 100 mcg/dose | ||||
| 19.2 | Ciprofloxacin | P,S,T | Drops 0.3 % | |
| 19.3 | Clotrimazole | P,S,T | Drops 1% | |
| 19.4 | Xylometazoline | P,S,T | Nasal drops 0.05 % | |
| Nasal drops 0.1 % | ||||
| Section 20–Gastrointestinal medicines | ||||
| 20.1–Antiulcer medicines | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Capsule 10 mg | ||||
| 20.1.1 | Omeprazole | P,S,T | Capsule 20 mg | |
| Capsule 40 mg | ||||
| Powder for oral liquid 20 mg | ||||
| 20.1.2 | Pantoprazole | S,T | Injection 40 mg | |
Page 49 of 117
| Tablet 150 mg | ||||
| 20.1.3 | Ranitidine | P,S,T | Oral liquid 75 mg/5 ml | |
| Injection 25 mg/ml | ||||
| 20.1.4 | Sucralfate | S,T | Oral liquid 1 g | |
| 20.2–Antiemetics | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 20.2.1 | Domperidone | P,S,T | Tablet 10 mg | |
| Oral liquid 1 mg/ml | ||||
| 20.2.2 | Metoclopramide | P,S,T | Injection 5 mg/ml | |
| Tablet 4 mg | ||||
| 20.2.3 | Ondansetron | S,T | Oral liquid 2 mg/5 ml | |
| Injection 2 mg/ml | ||||
| 20.3–Anti inflammatory medicines | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 5-aminosalicylic | Tablet 400 mg | |||
| 20.3.1 | S,T | Suppository 500 mg | ||
| acid | ||||
| Retention Enema | ||||
| Page 50 of 117 | ||||
20.4–Antispasmodic medicines
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Tablet 10 mg | ||||
| 20.4.1 | Dicyclomine | P,S,T | Oral Solution 10mg/5ml | |
| Injection 10 mg/ml | ||||
| 20.4.2 | Hyoscine | P,S,T | Tablet 10 mg | |
| butylbromide | Injection 20 mg/ml | |||
| 20.5–Laxatives | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 20.5.1 | Bisacodyl | P,S,T | Tablet 5 mg | |
| Suppository 5 mg | ||||
| 20.5.2 | Ispaghula | P,S,T | Granules/ Husk/ Powder | |
| 20.5.3 | Lactulose | S,T | Oral liquid 10 g/15 ml | |
20.6–Medicines used in diarrhoea
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 20.6.1 | Oral rehydration | P,S,T | As licensed | |
| salts | ||||
| 20.6.2 | Zinc sulphate | P,S,T | Dispersible Tablet 20 mg | |
| 20.7–Other medicines | ||||
| 20.7.1 | Somatostatin | T | Powder for Injection 3 mg | |
| Section 21–Hormones, other endocrine medicines and contraceptives | ||||
| 21.1–Adrenal hormones and synthetic substitutes | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 21.1.1 | Dexamethasone | S,T | Tablet 0.5 mg | |
| Injection 4 mg/ml | ||||
| 21.1.2 | Human chorionic | T | Injection 1000 IU | |
| gonadotropin | Injection 5000 IU | |||
| Tablet 5 mg | ||||
| 21.1.3 | Hydrocortisone | P,S,T | Tablet 10 mg | |
| Injection 100 mg/ml | ||||
| Page 52 of 117 | ||||
| Tablet 8 mg | ||||
| 21.1.4 | Methylprednisolon | S,T | Tablet 16 mg | |
| e | Tablet 32 mg | |||
| Injection 40 mg/ml | ||||
| Tablet 5 mg | ||||
| 21.1.5 | Prednisolone | P,S,T | Tablet 10 mg | |
| Tablet 20 mg | ||||
| 21.2–Contraceptives | ||||
| 21.2.1–Hormonal contraceptives | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Ethinylestradiol | ||||
| 21.2.1.1 | (A) + | P,S,T | Tablet 0.03 mg (A) + 0.15 mg (B) | |
| Levonorgestrel | ||||
| Ethinylestradiol | ||||
| 21.2.1.2 | (A) + | P,S,T | Tablet 0.035 mg (A) + 1 mg (B) | |
| Norethisterone | ||||
| 21.2.2–Intrauterine devices | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 21.2.2.1 | Hormone releasing | T | Contains 52 mg of Levonorgestrel | |
| IUD | ||||
| 21.2.2.2 | IUD containing | P,S,T | As licensed | |
| Copper | ||||
| Page 53 of 117 | ||||
21.2.3–Barrier methods
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| As per the standards prescribed in | ||||
| 21.2.3.1 | Condom | P,S,T | Schedule R of Drugs and Cosmetics | |
| rules, 1945 | ||||
| 21.3–Estrogens | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 21.3.1 | Ethinylestradiol | P,S,T | Tablet 0.01 mg | |
| Tablet 0.05 mg | ||||
| 21.3.2 | Levonorgestrel | P,S,T | Tablet 0.75 mg | |
21.4–Medicines used in diabetes mellitus
21.4.1–Insulins and other antidiabetic agents
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 21.4.1.1 | Glimepiride | P,S,T | Tablet 1 mg | |
| Tablet 2 mg | ||||
| 21.4.1.2 | Insulin (Soluble) | P,S,T | Injection 40 IU/ml | |
Page 54 of 117
| Intermediate | ||||
| 21.4.1.3 | Acting (NPH) | P,S,T | Injection 40 IU/ml | |
| Insulin | ||||
| Tablet 500 mg | ||||
| 21.4.1.4 | Metformin | P,S,T | Tablet 750 mg | |
| Tablet 1000 mg | ||||
| (Immediate and controlled release) | ||||
| Premix Insulin | ||||
| 21.4.1.5 | 30:70 Injection | P,S,T | Injection 40 IU/ml | |
| (Regular:NPH) | ||||
| 21.4.2–Medicines used to treat hypoglycemia | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 21.4.2.1 | Glucose | P,S,T | Injection 25 % | |
| 21.5–Ovulation Inducers | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 21.5.1 | Clomiphene | T | Tablet 50 mg | |
| Tablet 100 mg | ||||
| 21.6–Progestogens | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 21.6.1 | Medroxyprogester | P,S,T | Tablet 5 mg | |
| oneacetate | Tablet 10 mg | |||
Page 55 of 117
| 21.6.2 | Norethisterone | P,S,T | Tablet 5 mg |
21.7–Thyroid and antithyroid medicines
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 21.7.1 | Carbimazole | P,S,T | Tablet 5 mg | |
| Tablet 10 mg | ||||
| Tablet 12.5 mcg to 150 mcg* | ||||
| (Several strengths are available in | ||||
| 21.7.2 | Levothyroxine | P,S,T | market such as 12.5, 25, 50, 62.5, | |
| 75, 88, 100, 112 mcg. Therefore it | ||||
| was considered to give a range of | ||||
| available strengths) | ||||
Section 22–Immunologicals
In case of these biologicals, irrespective of variation in source, composition and strengths, all the products of the same vaccine/ sera/ immunoglobulin, as approved by licensing authority are considered as included in NLEM. However, considering the source, process, technology and other relevant aspects, different products of the same biologicals should be considered differently for purposes such as procurement policy, pricing etc.
22.1–Diagnostic agents
| Medicine | Level of | ||
| Healthcare | |||
| Tuberculin, | |||
| 22.1.1 | Purified Protein | P,S,T | |
| derivative | |||
22.2–Sera and immunoglobulins (Liquid/ Lyophilized)
| Medicine | Level of | ||
| Healthcare | |||
| 22.2.1 | Anti-rabies | P,S,T | |
| immunoglobulin | |||
| 22.2.2 | Anti-tetanus | P,S,T | |
| immunoglobulin | |||
| 22.2.3 | Anti-D | S, T | |
| immunoglobulin | |||
| 22.2.4 | Diphtheria | P,S,T | |
| antitoxin | |||
| 22.2.5 | Hepatitis B | S,T | |
| immunoglobulin | |||
| 22.2.6 | Human normal | T | |
| immunoglobulin | |||
| Snake venom | |||
| antiserum | |||
| 22.2.7 | a) Soluble/ liquid | P,S,T | |
| polyvalent | |||
| b) Lyophilized | |||
| polyvalent | |||
| 22.3–Vaccines | |||
- a)All the vaccines which are under Universal Immunization Programme of India (UIP) will be deemed included in NLEM. Presently, the UIP has BCG, DPT, OPV, measles, Hepatitis B, Japanese encephalitis & Pentavalent Vaccines.
- b)The new vaccines, which have been approved by National Technical Advisory Group on Immunization (NTAGI)and planned to be given under UIP, will be deemed to be included as and when listed in UIP. These vaccines are inactivated polio vaccine (IPV), Measles Rubella (MR) and Rota virus vaccine.
- c)In future, the vaccines which are under consideration , if and when included in UIP, will also be deemed included from the date of inclusion in UIP. These are pneumococcal and HPV vaccines.
22.3.1–For universal immunisation
| Medicine | Level of | ||
| Healthcare | |||
| 22.3.1.1 | BCG vaccine | P,S,T | |
| 22.3.1.2 | DPT + Hib + Hep | P,S,T | |
| B vaccine | |||
| 22.3.1.3 | DPT vaccine | P,S,T | |
| 22.3.1.4 | Hepatitis B vaccine | P,S,T | |
| Japanese | |||
| 22.3.1.5 | encephalitis | P,S,T | |
| vaccine | |||
| 22.3.1.6 | Measles vaccine | P,S,T | |
| 22.3.1.7 | Oral poliomyelitis | P,S,T | |
| vaccine | |||
Page 58 of 117
| 22.3.1.8 | Tetanus toxoid | P,S,T | ||
| 22.3.2–For Specific Group of Individuals | ||||
| Medicine | Level of | |||
| Healthcare | ||||
| 22.3.2.1 | Rabies vaccine | P,S,T | ||
| Section 23–Muscle relaxants and | ||||
| cholinesterase inhibitors | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 23.1 | Atracurium | S,T | Injection 10 mg/ml | |
| Tablet 5 mg | ||||
| 23.2 | Baclofen | S,T | Tablet 10 mg | |
| Tablet 20 mg | ||||
| 23.3 | Neostigmine | S,T | Tablet 15 mg | |
| Injection 0.5 mg/ml | ||||
| 23.4 | Succinylcholine | S,T | Injection 50 mg/ml | |
| 23.5 | Vecuronium | S,T | Powder for Injection 4 mg | |
| Powder for Injection 10 mg | ||||
Page 59 of 117
Section 24–Medicines for neonatal care
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 24.1 | Alprostadil | T | Injection 0.5 mg/ml | |
| 24.2 | Caffeine | S,T | Oral liquid 20 mg/ml | |
| Injection 20 mg/ml | ||||
| 24.3 | Surfactant | S,T | Suspension for intratracheal | |
| instillation (As liensed) | ||||
| Section 25–Ophthalmological Medicines | ||||
| 25.1–Anti-infective medicine | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 25.1.1 | Acyclovir | P,S,T | Ointment 3% | |
| 25.1.2 | Ciprofloxacin | P,S,T | Drops 0.3 % | |
| Ointment 0.3% | ||||
| 25.1.3 | Erythromycin | P,S,T | Ointment 0.5% | |
Page 60 of 117
| 25.1.4 | Gentamicin | P,S,T | Drops 0.3% | |
| 25.1.5 | Natamycin | P,S,T | Drops 5% | |
| 25.1.6 | Povidone iodine | P,S,T | Drops 0.6% | |
| Drops 5% | ||||
| 25.2–Antiinflammatory medicine | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 25.2.1 | Prednisolone | P,S,T | Drops 0.1% | |
| Drops 1% | ||||
| 25.3–Local anaesthetics | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 25.3.1 | Proparacaine | P,S,T | Drops 0.5% | |
| 25.4–Miotics and antiglaucoma medicines | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 25.4.1 | Acetazolamide | P,S,T | Tablet 250 mg | |
| 25.4.2 | Pilocarpine | P,S,T | Drops 2% | |
| Drops 4% | ||||
| Page 61 of 117 | ||||
| 25.4.3 | Timolol | P,S,T | Drops 0.25% | |
| Drops 0.5% | ||||
| 25.5–Mydriatics | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 25.5.1 | Atropine | P,S,T | Drops 1% | |
| Ointment 1% | ||||
| 25.5.2 | Homatropine | P,S,T | Drops 2% | |
| 25.5.3 | Phenylephrine | P,S,T | Drops 5% | |
| Drops 10 % | ||||
| 25.5.4 | Tropicamide | P,S,T | Drops 1% | |
| 25.6–Ophthalmic surgical aids | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 25.6.1 | Hydroxypropyl | T | Injection 2% | |
| methylcellulose | ||||
Page 62 of 117
25.7–Miscellaneous
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 25.7.1 | Carboxymethylcell | P,S,T | Drops 0.5% | |
| ulose | Drops 1 % | |||
| Section 26–Oxytocics and Antioxytocics | ||||
| 26.1–Oxytocics and abortifacient | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 26.1.1 | Dinoprostone | S,T | Tablet 0.5 mg | |
| Gel 0.5 mg | ||||
| 26.1.2 | Methylergometrine | P,S,T | Tablet 0.125 mg | |
| Injection 0.2 mg/ml | ||||
| 26.1.3 | Mifepristone | T | Tablet 200 mg | |
| 26.1.4 | Misoprostol | T | Tablet 100 mcg | |
| Tablet 200 mcg | ||||
| 26.1.5 | Oxytocin | S,T | Injection 5 IU/ml | |
| Injection 10 IU/ml | ||||
Page 63 of 117
26.2–Medicines used in pre term labour
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 26.2.1 | Betamethasone | P,S,T | Injection 4 mg/ml | |
| 26.2.2 | Nifedipine | S,T | Tablet 10 mg | |
| Section 27–Psychotherapeutic medicines | ||||
| 27.1–Medicines used in psychotic disorders | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Tablet 25 mg | ||||
| 27.1.1 | Clozapine | T | Tablet 50 mg | |
| Tablet 100 mg | ||||
| 27.1.2 | Fluphenazine | S,T | Depot Injection 25 mg/ml | |
| Tablet 5 mg | ||||
| 27.1.3 | Haloperidol | S,T | Tablet 10 mg | |
| Tablet 20 mg | ||||
| Oral liquid 2 mg/ 5ml | ||||
| Tablet 1 mg | ||||
| 27.1.4 | Risperidone | P,S,T | Tablet 2 mg | |
| Tablet 4 mg | ||||
| Oral liquid 1 mg/ml | ||||
Page 64 of 117
27.2–Medicines used in mood disorders
27.2.1–Medicines used in depressive disorders
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Tablet 10 mg | ||||
| 27.2.1.1 | Amitriptyline | P,S,T | Tablet 25 mg | |
| Tablet 50 mg | ||||
| Tablet 75 mg | ||||
| Tablet 5 mg | ||||
| 27.2.1.2 | Escitalopram | S,T | Tablet 10 mg | |
| Tablet 20 mg | ||||
| Capsule 10 mg | ||||
| 27.2.1.3 | Fluoxetine | P,S,T | Capsule 20 mg | |
| Capsule 40 mg | ||||
| Capsule 60 mg | ||||
| 27.2.2–Medicines used in Bipolar disorders | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 27.2.2.1 | Lithium | S,T | Tablet 300 mg | |
| 27.2.2.2 | Sodium valproate | P,S,T | Tablet 200 mg | |
| Tablet 500 mg | ||||
27.3–Medicines used for Generalized Anxiety and Sleep Disorders
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Tablet 0.25 mg | ||||
| 27.3.1 | Clonazepam | P,S,T | Tablet 0.5 mg | |
| Tablet 1 mg | ||||
| 27.3.2 | Zolpidem | P,S,T | Tablet 5 mg | |
| Tablet 10 mg | ||||
27.4–Medicines used for obsessive compulsive disorders and panic attacks
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Capsule 10 mg | ||||
| 27.4.1 | Clomipramine | S,T | Capsule 25 mg | |
| Capsule 75 mg | ||||
| Capsule 10 mg | ||||
| 27.4.2 | Fluoxetine | P,S,T | Capsule 20 mg | |
| Capsule 40 mg | ||||
| Capsule 60 mg | ||||
Section 28–Medicines acting on the respiratory tract
28.1–Antiasthmatic medicines
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Inhalation (MDI/DPI) 100 | ||||
| mcg/dose | ||||
| Inhalation (MDI/DPI) 200 | ||||
| 28.1.1 | Budesonide | P,S,T | mcg/dose | |
| Respirator solution for use in | ||||
| nebulizer 0.5 mg/ml | ||||
| Respirator solution for use in | ||||
| nebulizer 1 mg/ml | ||||
| Inhalation (MDI/DPI) 100 mcg (A) | ||||
| + 6 mcg (B) | ||||
| 28.1.2 | Budesonide (A)+ | P,S,T | Inhalation (MDI/DPI) 200 mcg (A) | |
| Formoterol (B) | + 6 mcg (B) | |||
| Inhalation (MDI/DPI) 400 mcg (A) | ||||
| + 6 mcg (B) | ||||
| 28.1.3 | Hydrocortisone | P,S,T | Injection 100 mg | |
| Injection 200 mg | ||||
| Inhalation (MDI/DPI) 20 mcg/dose | ||||
| 28.1.4 | Ipratropium | P,S,T | Respirator solution for use in | |
| nebulizer 250 mcg/ml | ||||
Page 67 of 117
| Tablet 2 mg | ||||
| Tablet 4 mg | ||||
| Oral liquid 2 mg/5 ml | ||||
| 28.1.5 | Salbutamol | P,S,T | Inhalation (MDI/DPI) 100 | |
| mcg/dose | ||||
| Respirator solution for use in | ||||
| nebulizer 5mg/ml | ||||
| 28.1.6 | Tiotropium | P,S,T | Inhalation (MDI) 9 mcg/dose | |
| Inhalation (DPI) 18 mcg/dose | ||||
| MDI- Metered dose inhaler | ||||
| DPI- Dry Powder inhaler | ||||
| Section 29–Solutions correcting water, electrolyte disturbances and | ||||
| acid-base disturbances | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| Injection 5% | ||||
| 29.1 | Glucose | P,S,T | Injection 10% | |
| Injection 25% | ||||
| Injection 50% | ||||
| Glucose (A) + | ||||
| 29.2 | Sodium chloride | P,S,T | Injection 5% (A) + 0.9% (B) | |
| (B) | ||||
| 29.3 | Oral rehydration | P,S,T | As licensed | |
| salts | ||||
| 29.4 | Potassium chloride | P,S,T | Injection 150 mg/ml | |
| Oral liquid 500 mg/5 ml | ||||
| 29.5 | Ringer lactate | P,S,T | Injection (as per IP) | |
Page 68 of 117
| 29.6 | Sodium | P,S,T | Injection (as per IP) | |
| bicarbonate | ||||
| P,S,T | Injection 0.9% | |||
| 29.7 | Sodium chloride | |||
| S,T | Injection 0.45% | |||
| Injection 3% | ||||
| 29.3–Miscellaneous | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 29.3.1 | Water for Injection | P,S,T | Injection | |
| Section 30–Vitamins and minerals | ||||
| Medicine | Level of | Dosage form and strength | ||
| Healthcare | ||||
| 30.1 | Ascorbic acid | P,S,T | Tablet 100 mg | |
| (Vitamin C) | Tablet 500 mg | |||
| 30.2 | Calcium carbonate | P,S,T | Tablet 250 mg | |
| Tablet 500 mg | ||||
| 30.3 | Calcium gluconate | P,S,T | Injection 100 mg/ml | |
Page 69 of 117
| Tablet 1000 IU, | ||||
| 30.4 | Cholecalciferol | P,S,T | Tablet 60000 IU | |
| Oral liquid 400 IU/ml | ||||
| 30.5 | Nicotinamide | P,S,T | Tablet 50 mg | |
| Tablet 10 mg | ||||
| 30.6 | Pyridoxine | P,S,T | Tablet 50 mg | |
| Tablet 100 mg | ||||
| 30.7 | Riboflavin | P,S,T | Tablet 5 mg | |
| 30.8 | Thiamine | P,S,T | Tablet 100 mg | |
| Injection 100 mg/ml | ||||
| Capsule 5000 IU | ||||
| Capsule 50000 IU | ||||
| 30.9 | Vitamin A | P,S,T | Capsule 100000 IU | |
| Oral liquid 100000 IU/ml | ||||
| Injection 50000 IU/ml | ||||
Alphabetical list of medicines in NLEM 2015
- 5-aminosalicylic acid
- 5-Fluorouracil
- 6-Mercaptopurine
- Abacavir
- Abacavir + Lamivudine
- Acetazolamide
- Acetylsalicylic acid
- Actinomycin D
- Activated charcoal
- Acyclovir
- Adenosine
- Adrenaline
- Albendazole
- Allopurinol
- All-trans retinoic acid
- Alprostadil
- Alteplase
- Amiodarone
- Amitriptyline
- Amlodipine
- Amoxicillin
- Amoxicillin + Clavulanic acid Amphotericin B
- a) Amphotericin B (conventional) b) Lipid/ Liposomal Amphotericin B
- Ampicillin
- Anti-D immunoglobulin
- Anti-rabies immunoglobulin
- Anti-tetanus immunoglobulin
- Arsenic Trioxide
- Artemether + Lumefantrine
- Artesunate
- Artesunate + Sulphadoxine – Pyrimethamine
- Ascorbic acid (Vitamin C)
- Atazanavir + Ritonavir
- Atenolol
- Atorvastatin
- Atracurium
- Atropine
- Azathioprine
- Azithromycin
- Baclofen
- Barium sulphate
- BCG vaccine
- Benzathine benzylpenicillin
- Benzoyl peroxide
- Benzyl penicillin
- Betamethasone
- Bicalutamide
- Bisacodyl
- Bleaching powder
- Bleomycin
- Bortezomib
- Budesonide
- Budesonide + Formoterol
- Bupivacaine
- Caffeine
- Calamine
- Calcium carbonate
- Calcium folinate
- Calcium gluconate
- Capecitabine
- Capreomycin
- Carbamazepine
- Carbimazole
- Carboplatin
- Carboxymethylcellulose
- Cefadroxil
- Cefazolin
- Cefixime
- Cefotaxime
- Ceftazidime
- Ceftriaxone
- Cetirizine
- Cetrimide
- hlorambucil
- Chlorhexidine
- Chloroquine
- Chlorpheniramine
- Cholecalciferol
- Ciprofloxacin
- Cisplatin
- Clarithromycin
- Clindamycin
- Clobazam
- Clofazimine
- Clomiphene
- Clomipramine
- Clonazepam
- Clopidogrel
- Clotrimazole
- Cloxacillin
- Clozapine
- Coagulation factor IX
- Coagulation factor VIII
- Coal tar
- Colchicine
- Condom
- Co-trimoxazole [Sulphamethoxazole + Trimethoprim ]
- Cryoprecipitate
Page 74 of 117
Alphabetical list of medicines in NLEM 2015
- Cyclophosphamide
- Cycloserine
- Cyclosporine
- Cytosine arabinoside
- Dacarbazine
- Dapsone
- Darunavir
- Daunorubicin
- Desferrioxamine
- Dexamethasone
- Dextran-40
- Diazepam
- Diclofenac
- Dicyclomine
- Diethylcarbamazine
- Digoxin
- Diloxanide furoate
- Diltiazem
- Dimercaprol
- Dinoprostone
- Diphtheria antitoxin
- Dobutamine
- Docetaxel
- Domperidone
- Donepezil
Page 75 of 117
Alphabetical list of medicines in NLEM 2015
- Dopamine
- Doxorubicin
- Doxycycline
- DPT + Hib + Hep B vaccine
- DPT vaccine
- Efavirenz
- Enalapril
- Enoxaparin
- Entecavir
- Erythromycin
- Erythropoietin
- Escitalopram
- Esmolol
- Ethambutol
- Ethinylestradiol
- Ethinylestradiol + Levonorgestrel
- Ethinylestradiol + Norethisterone
- Ethionamide
- Ethyl alcohol (Denatured)
- Etoposide
- Fentanyl
- Ferrous salt + Folic acid
- Ferrous salts
- Filgrastim
Page 76 of 117
Alphabetical list of medicines in NLEM 2015
- Fluconazole
- Flunarizine
- Fluorescein
- Fluoxetine
- Fluphenazine
- Folic acid
- Framycetin
- Fresh frozen plasma
- Furosemide
- Fusidic acid
- Gadobenate
- Ganciclovir
- Gefetinib
- Gemcitabine
- Gentamicin
- Glimepiride
- Glucose
- Glucose + Sodium chloride
- Glutaraldehyde
- Glycerin
- Glyceryl trinitrate
- Glycopyrrolate
- Griseofulvin
- Haemodialysis fluid
- Haloperidol
Page 77 of 117
Alphabetical list of medicines in NLEM 2015
- Halothane
- Heparin
- Hepatitis B immunoglobulin
- Hepatitis B vaccine
- Homatropine
- Hormone releasing IUD
- Human chorionic gonadotropin
- Human normal immunoglobulin
- Hydrochlorothiazide
- Hydrocortisone
- Hydrogen peroxide
- Hydroxocobalamin
- Hydroxychloroquine
- Hydroxypropyl methylcellulose
- Hydroxyurea
- Hyoscine butylbromide
- Ibuprofen
- Ifosfamide
- Imatinib
- Insulin (Soluble)
- Intermediate Acting (NPH) Insulin
- Intraperitoneal dialysis solution
- Iohexol
- Ipratropium
- Iron sucrose
Page 78 of 117
Alphabetical list of medicines in NLEM 2015
- Isoflurane
- Isoniazid
- Isosorbide-5-mononitrate
- Isosorbide dinitrate
- Ispaghula
- IUD containing Copper
- Japanese encephalitis vaccine
- Kanamycin
- Ketamine
- Labetalol
- Lactulose
- Lamivudine + Nevirapine + Stavudine
- Lamivudine + Zidovudine
- L-Asparaginase
- Leflunomide
- Letrozole
- Levetiracetam
- Levodopa + Carbidopa
- Levofloxacin
- Levonorgestrel
- Levothyroxine
- Lignocaine
- Lignocaine + Adrenaline
- Linezolid
Page 79 of 117
Alphabetical list of medicines in NLEM 2015
- Lithium
- Loperamide
- Lopinavir + Ritonavir
- Lorazepam
- Magnesium sulphate
- Mannitol
- Measles vaccine
- Mebendazole
- Medroxyprogesteroneacetate
- Mefenamic acid
- Mefloquine
- Meglumine diatrizoate
- Melphalan
- Mesna
- Metformin
- Methotrexate
- Methyldopa
- Methylergometrine
- Methylprednisolone
- Methylrosanilinium chloride (Gentian Violet)
- Methylthioninium chloride (Methylene blue)
- Metoclopramide
- Metoprolol
- Metronidazole
Page 80 of 117
Alphabetical list of medicines in NLEM 2015
- Midazolam
- Mifepristone
- Miltefosine
- Misoprostol
- Morphine
- Moxifloxacin
- Mycophenolate mofetil
- N-acetylcysteine
- Naloxone
- Natamycin
- Neostigmine
- Nevirapine
- Nicotinamide
- Nifedipine
- Nitrofurantoin
- Nitrous oxide
- Nor adrenaline
- Norethisterone
- Nystatin
- Omeprazole
- Ondansetron
- Oral poliomyelitis vaccine
- Oral rehydration salts
- Oxaliplatin
- Oxygen
Page 81 of 117
Alphabetical list of medicines in NLEM 2015
- Oxytocin
- Paclitaxel
- Pantoprazole
- Para-aminosalicylic acid
- Paracetamol
- Paromomycin
- Pegylated interferon alfa 2a/ 2b
- Penicillamine
- Pentamidine
- Permethrin
- Pheniramine
- Phenobarbitone
- Phenylephrine
- Phenytoin
- Phytomenadione (Vitamin K1)
- Pilocarpine
- Piperacillin + Tazobactam
- Platelet rich plasma
- Podophyllin resin
- Potassium chloride
- Potassium permanganate
- Povidone iodine
- Pralidoxime chloride (2-PAM)
- Praziquantel
- Prednisolone
Page 82 of 117
Alphabetical list of medicines in NLEM 2015
- Premix Insulin 30:70 Injection (Regular:NPH)
- Prilocaine + Lignocaine
- Primaquine
- Procarbazine
- Proparacaine
- Propofol
- Propranolol
- Protamine
- Pyrazinamide
- Pyridoxine
- Quinine
- Rabies vaccine
- Raltegravir
- Ramipril
- Ranitidine
- Red blood cells
- Ribavirin
- Riboflavin
- Rifabutin
- Rifampicin
- Ringer lactate
- Risperidone
- Ritonavir
- Rituximab
Page 83 of 117
Alphabetical list of medicines in NLEM 2015
- Salbutamol
- Salicylic acid
- Sevoflurane
- Silver sulphadiazine Snake venom antiserum
- a) Soluble/ liquid polyvalent b) Lyophilized polyvalent
- Sodium bicarbonate
- Sodium chloride
- Sodium nitrite
- Sodium nitroprusside
- Sodium thiosulphate
- Sodium valproate
- Sofosbuvir
- Somatostatin
- Spironolactone
- Stavudine + Lamivudine
- Streptokinase
- Streptomycin
- Succinylcholine
- Sucralfate
- Sulfasalazine
- Sumatriptan
- Surfactant
- Tacrolimus
- Tamoxifen
Page 84 of 117
Alphabetical list of medicines in NLEM 2015
- Telmisartan
- Temozolomide
- Tenofovir
- Tenofovir + Lamivudine
- Tenofovir + Lamivudine + Efavirenz
- Tetanus toxoid
- Thalidomide
- Thiamine
- Thiopentone
- Timolol
- Tiotropium
- Tramadol
- Tranexamic acid
- Trastuzumab
- Trihexyphenidyl
- Tropicamide
- Tuberculin, Purified Protein derivative
- Vancomycin
- Vecuronium
- Verapamil
- Vinblastine
- Vincristine
- Vitamin A
- Warfarin
Page 85 of 117
Alphabetical list of medicines in NLEM 2015
- Water for Injection
- White Petrolatum
- Whole blood
- Xylometazoline
- Zidovudine
- Zidovudine + Lamivudine + Nevirapine
- Zinc sulphate
- Zoledronic acid
- Zolpidem
Page 86 of 117
Medicines Added to NLEM 2011
| Ref no | Medicines added |
Section 1–Anesthetic agents
1.3.2 Glycopyrrolate
Section 2– Analgesics, antipyretics, non steroidal anti inflammatory medicines, medicines used to treat gout and disease modifying agents used in rheumatoid disorders
2.1.4 Mefenamic acid
Section 3–Antiallergics and medicines used in anaphylaxis
NIL
Section 4–Antidotes and other substances used in poisonings
| 4.2.9 | * Neostigmine (Also listed in section 23- Muscle Relaxants and | |
| Cholinesterase Inhibitors) | ||
| Section 5–Anticonvulsants / Antiepileptics | ||
| 5.2 | Clobazam |
| 5.4 | Levetiracetam |
Section 6.1–Anti-helminthics
6.1.1.2 Mebendazole
Page 87 of 117
Medicines Added to NLEM 2011
Section 6.2–Anti-bacterial medicines
6.2.1.5 Benzyl penicillin
6.2.1.6 Cefadroxil
6.2.1.7 Cefazolin
6.2.1.13 Piperacillin + Tazobactam
6.2.2.3 Clarithromycin
Section 6.2.3–Antileprosy medicines
NIL
Section 6.2.4–Antituberculosis medicines
6.2.4.1 Capreomycin
6.2.4.2 Cycloserine
6.2.4.4 Ethionamide
6.2.4.6 Kanamycin
6.2.4.7 Levofloxacin
Page 88 of 117
Medicines Added to NLEM 2011
6.2.4.8 Linezolid
6.2.4.9 Moxifloxacin
6.2.4.10 Para amino salicylic acid
6.2.4.12 Rifabutin
Section 6.3–Anti-fungal medicines
NIL
Section 6.4–Antiviral medicines
6.4.2.1 Ganciclovir
6.4.3.1.1 Abacavir
6.4.3.1.2 Abacavir + Lamivudine
6.4.3.1.6 Tenofovir + Lamivudine
6.4.3.1.7 Tenofovir + Lamivudine + Efavirenz
6.4.3.1.8 Raltegravir
6.4.3.3.1 Atazanavir + Ritonavir
Page 89 of 117
Medicines Added to NLEM 2011
6.4.3.4.2 Darunavir
6.4.3.3.2 Lopinavir + Ritonavir
6.4.4.1 Entecavir
6.4.4.2 Pegylated interferon alfa 2a and 2b
6.4.4.3 Ribavirin
6.4.4.4 Sofosbuvir
6.4.4.5 Tenofovir
Section 6.5–Anti-Protozoal medicines
6.5.2.2 Miltefosine
6.5.2.3 Paromomycin
6.5.3.1.1 Artemether + Lumefantrine
6.5.3.1.2 Artesunate
Section 7–Antimigraine medicines
7.1.3 Sumatriptan
Page 90 of 117
Medicines Added to NLEM 2011
7.2.1 Flunarizine
Section 8–Antineoplastic, immunosuppressives and medicines used in palliative care
8.1.4 All trans retinoic acid
8.1.5 Arsenic Trioxide
8.1.6 Bortezomib
8.1.8 Capecitabine
8.1.16 Docetaxel
8.1.18 Gefitinib
8.1.31 Rituximab
8.1.32 Temozolomide
8.1.31 Thalidomide
8.1.34 Trastuzumab
8.2.1 Bicalutamide
8.2.2 Letrozole
Page 91 of 117
| Medicines Added to NLEM 2011 | ||
| 8.3.3 | Mycophenolate mofetil | |
| 8.3.4 | Tacrolimus | |
| 8.4.2 | *Amitriptyline (Also listed in Section 27–Psychotherapeutic | |
| Medicines) | ||
| *Dexamethasone (Also listed in Section: 21–Hormones, other | ||
| 8.4.3 | endocrine medicines and contraceptives and Section 3–Antiallergics | |
| and medicines used in anphylaxis) | ||
| 8.4.4 | *Diazepam (Also listed in Section 5–Anticonvulsants/ | |
| Antiepileptics) | ||
| *Fluoxetine (Also listed in Section 27 – Psychotherapeutic | ||
| 8.4.6 | Medicines in 27.2.1– Medicines used in depressive disorder and | |
| 27.4–Medicines used for obsessive compulsive disorders and panic | ||
| attacks ) | ||
| 8.4.7 | *Haloperidol (Also listed in Section 27–Psychotherapeutic | |
| Medicines) | ||
| 8.4.8 | *Lactulose (Also listed in Section 20–Gastrointestinal medicines) | |
| 8.4.9 | Loperamide | |
| 8.4.10 | *Metoclopramide (Also listed in Section 20–Gastrointestinal | |
| medicines) | ||
| 8.4.11 | *Midazolam (Also listed in Section 1–Anesthetic agents) | |
| *Tramadol (Also listed in Section 2– Analgesics, antipyretics, non | ||
| 8.4.14 | steroidal anti inflammatory medicines, medicines used to treat gout | |
| and disease modifying agents used in rheumatoid disorders) | ||
| 8.4.15 | Zoledronic acid | |
Page 92 of 117
Medicines Added to NLEM 2011
Section 9–Antiparkinsonism medicines
NIL
Section 10–Medicines affecting the blood
10.1.1 Erythropoietin
10.1.3 Ferrous salt + Folic acid
10.1.5 Hydroxocobalamin
10.1.6 Hydroxyurea
10.1.7 Iron sucrose
10.2.5 Tranexamic acid
Section 11–Blood products and plasma substitutes
11.1.3 Red blood cells
11.1.4 Whole blood
Section 12–Cardiovascular medicines
12.3.5 Labetalol
Page 93 of 117
Medicines Added to NLEM 2011
12.3.7 Ramipril
12.3.9 Telmisartan
12.4.4 Noradrenaline
12.5.2 Alteplase
Section 13–Medicines used in dementia
13.1 Donepezil
Section 14–Dermatological medicines
14.1.1 Clotrimazole (Also listed in Section 6- Anti infective medicines)
14.2.2 Fusidic acid
14.4.2 Benzoyl peroxide
14.2.4 Podophyllin resin
14.6.2 White Petrolatum
Section 15–Diagnostic agents
15.2.2 Gadobenate
Page 94 of 117
Medicines Added to NLEM 2011
15.2.3 Iohexol
Section 16–Dialysis solution
16.1 Haemodialysis fluid
Section 17–Disinfectants and antiseptics
NIL
Section 18–Diuretics
NIL
Section 19–Ear, nose and throat medicines
| 19.1 | *Budesonide (Also listed in Section 28- Medicines acting on | |
| respiratory tract) | ||
| 19.2 | *Ciprofloxacin (Also listed in Section 6- Anti infective medicines | |
| and Section 25- Ophthalmological medicines) | ||
| 19.3 | Clotrimazole ( Also listed in Section 6- Anti infective medicines) | |
| 19.4 | Xylometazoline | |
Section 20–Gastrointestinal medicines
20.1.4 Sucralfate
20.5.3 Lactulose
20.7.1 Somatostatin
Section 21–Hormones, other endocrine medicines and contraceptives
21.1.2 Human Chorionic Gonadotropin
21.3.2 Levonorgestrel
21.4.1.1 Glimepiride
Section 22–Immunologicals
22.2.5 Hepatitis B immunoglobulin
22.2.6 Human Normal Immunoglobulin
22.3.1.2 DPT + Hib + Hep B vaccine
22.3.2.1 Japanese encephalitis vaccine
Section 23–Muscle relaxants and cholinesterase inhibitors
23.2 Baclofen
Section 24 Medicines for neonatal care
24.1 Alprostadil
24.2 Caffeine
24.3 Surfactant
Section 25–Ophthalmological Medicines
25.1.1 *Acyclovir (Also listed in Section 6- Anti infective medicnes)
25.1.3 Erythromycin
25.1.5 Natamycin
25.3.1 Proparacaine
25.5.4 Tropicamide (Also listed in Section 15- Diagnostic agents)
25.7.1 Carboxymethylcellulose
Section 26–Oxytocics and Antioxytocics
26.1.1 Dinoprostone
Section 27–Psychotherapeutics
27.1.1 Clozapine
27.1.2 Fluphenazine
27.1.4 Risperidone
27.2.1.2 Escitalopram
27.3.1 Clonazepam
27.3.2 Zolpidem
27.4.1 Clomipramine
Section 28–Medicines acting on the respiratory tract
28.1.1 Budesonide
28.1.2 Budesonide + Formoterol
28.1.6 Tiotropium
Section 29–Solutions correcting water, electrolyte disturbances and acid-base disturbances
NIL
Section: 30 –Vitamins and minerals
30.4 Cholecalciferol
- Abacavir
- Abacavir + Lamivudine
- All trans retinoic acid
- Alprostadil
- Alteplase
- Arsenic Trioxide
- Artemether + Lumefantrine
- Artesunate
- Atazanavir + Ritonavir
- Baclofen
- Benzoyl peroxide
- Benzyl penicillin
- Bicalutamide
- Bortezomib
- Budesonide
- Budesonide + Formoterol
- Caffeine
- Capecitabine
- Capreomycin
- Carboxymethylcellulose
- Cefadroxil
- Cefazolin
- Cholecalciferol
- Clarithromycin
- Clobazam
- Clomipramine
- Clonazepam
- Clozapine
- Cycloserine
- Darunavir
- Dinoprostone
- Docetaxel
- Donepezil
- DPT + Hib + Hep B vaccine
- Entecavir
- Erythropoietin
Page 99 of 117
Alphabetical List of Medicines Added to NLEM 2011
- Escitalopram
- Ethionamide
- Ferrous salt + Folic acid
- Flunarizine
- Fluphenazine
- Fusidic acid
- Gadobenate
- Ganciclovir
- Gefitinib
- Glimepiride
- Glycopyrrolate
- Haemodialysis fluid
- Hepatitis B immunoglobulin
- Human Chorionic Gonadotropin
- Human Normal Immunoglobulin
- Hydroxocobalamin
- Hydroxyurea
- Iohexol
- Iron sucrose
- Japanese encephalitis vaccine
- Kanamycin
- Labetalol
- Lactulose
- Letrozole
- Levetiracetam
- Levofloxacin
- Levonorgestrel
- Linezolid
- Loperamide
- Lopinavir + Ritonavir
- Mebendazole
- Mefenamic acid
- Miltefosine
- Moxifloxacin
- Mycophenolate mofetil
- Natamycin
- Noradrenaline
- Para amino salicylic acid
- Paromomycin
- Pegylated interferon alfa 2a and 2b
- Piperacillin + Tazobactam
- Podophyllin resin
- Proparacaine
- Raltegravir
- Ramipril
- Red blood cells
- Ribavirin
- Rifabutin
- Risperidone
- Rituximab
- Sofosbuvir
- Somatostatin
- Sucralfate
- Sumatriptan
- Surfactant
- Tacrolimus
- Telmisartan
- Temozolomide
- Tenofovir
- Tenofovir + Lamivudine
- Tenofovir + Lamivudine + Efavirenz
- Thalidomide
- Tiotropium
- Tranexamic acid
- Trastuzumab
- White Petrolatum
- Whole blood
- Xylometazoline
- Zoledronic acid
- Zolpidem
| S.No. | Medicines deleted |
Section 1–Anesthetic agents
1 Ether
2 Diazepam
3 Promethazine
Section 2– Analgesics, antipyretics, non steroidal anti inflammatory medicines, medicines used to treat gout and disease modifying agents used in rheumatoid disorders
NIL
Section 3–Antiallergics and medicines used in anaphylaxis
1 Dexchlorpheniramine
2 Promethazine
Section 4–Antidotes and other substances used in poisonings
1 Flumazenil
Section 5–Anticonvulsants / Antiepileptics
NIL
Section 6.1–Anti-helminthics
1 Piperazine
Section 6.2–Anti-bacterial medicines
1 Cephalexin
2 Amikacin
3 Sulfadiazine
4 Erythromycin
Section 6.2.3–Antileprosy medicines
NIL
Section 6.2.4–Antituberculosis medicines
1 Ofloxacin
Section 6.3–Anti-fungal medicines
NIL
Section 6.4–Antiviral medicines
| Medicines Deleted from NLEM 2011 | |
| 1 | Didanosine |
| 2 | Lamivudine |
| 3 | Stavudine |
| 4 | Indinavir |
| 5 | Nelfinavir |
| 6 | Saquinavir |
| Section 6.5–Anti-Protozoal medicines | |
| 1 | Pentamidine |
| 2 | Sodium Stibogluconate |
| 3 | Pyrimethamine |
| 4 | Sulfadoxine + Pyrimethamine |
Section 7–Antimigraine medicines
1 Dihydroergotamine
Section 8–Antineoplastic, immunosuppressives and medicines used in palliative care
1 Alpha interferon
Page 104 of 117
| Medicines Deleted from NLEM 2011 | |
| 2 | Busulfan |
| 3 | Mitomycin-C |
| 4 | Danazol |
| 5 | Flutamide |
| 6 | Raloxifene |
| Section 9–Antiparkinsonism medicines | |
| 1 | Bromocriptine Mesylate |
| Section 10–Medicines affecting the blood | |
| 1 | Cyanocobalamin |
| 2 | Iron dextran |
| 3 | Pyridoxine |
| Section 11–Blood products and plasma substitutes | |
| 1 | Dextran 70 |
| 2 | Hydroxyethyl starch (Hetastarch) |
Page 105 of 117
| Medicines Deleted from NLEM 2011 | |
| 3 | Polygeline |
| 4 | Albumin |
| Section 12–Cardiovascular medicines | |
| 1 | Diltiazem |
| 2 | Procainamide |
| 3 | Losartan potassium |
| 4 | Nifedipine |
| 5 | Urokinase |
Section 13–Medicines used in dementia
NIL
Section 14–Dermatological medicines
| 1 | Miconazole |
| 2 | Acyclovir |
| 3 | Neomycin + Bacitracin |
Page 106 of 117
| Medicines Deleted from NLEM 2011 | |
| 4 | Zinc Oxide |
| 5 | Dithranol |
| 6 | Benzyl benzoate |
| Section 15–Diagnostic agents | |
| 1 | Calcium Ipodate |
| 2 | Iopanoic Acid |
| 3 | Meglumine Iothalamate |
| 4 | Meglumine Iotroxate |
| 5 | Propyliodone |
| 6 | Sodium Iothalamate |
| Section 23–Dialysis solution | |
| NIL | |
| Section 17–Disinfectants and antiseptics | |
| 1 | Acriflavin + Glycerin |
Page 107 of 117
Medicines Deleted from NLEM 2011
2 Benzoin compound
3 Formaldehyde
Section 18–Diuretics
NIL
Section 19–Ear, nose and throat medicines
NIL
Section 20–Gastrointestinal medicines
1 Promethazine
2 Aluminium Hydroxide + Magnesium Hydroxide
3 Famotidine
Section 21–Hormones, other endocrine medicines and contraceptives
1 Testosterone
2 Glibenclamide
3 Glucagon
Page 108 of 117
Medicines Deleted from NLEM 2011
4 Iodine
Section 22–Immunologicals
NIL
Section 23–Muscle relaxants and cholinesterase inhibitors
1 Pyridostigmine
Section 24 Medicines for neonatal care
NIL
Section 25–Ophthalmological Medicines
1 Chloramphenicol
2 Miconazole
3 Sulphacetamide sodium
4 Tetracaine hydrochloride
5 Betaxolol hydrochloride
Section 26–Oxytotics and antioxytotics
1 Terbutaline
Section 27–Psychotherapeutics
| Medicines Deleted from NLEM 2011 | |
| 1 | Chlorpromazine |
| 2 | Olanzapine |
| 3 | Imipramine |
| 4 | Alprazolam |
| 5 | Diazepam |
| Section 28–Medicines acting on the respiratory tract | |
| 1 | Beclomethasone Dipropionate |
| 2 | Codeine Phosphate |
| 3 | Dextromethorphan |
Section 29–Solutions correcting water, electrolyte disturbances and acid-base disturbances
NIL
Section 30–Vitamins and minerals
| 1 | Multivitamins |
| 2 | Vitamin D (Ergocalciferol) |
Page 110 of 117
Alphabetical List of Medicines Deleted from NLEM 2011
- Acriflavin + Glycerin
- Albumin
- Alpha interferon
- Alprazolam
- Aluminium Hydroxide + Magnesium Hydroxide
- Amikacin
- Beclomethasone Dipropionate
- Benzoin compound
- Benzyl benzoate
- Betaxolol hydrochloride
- Bromocriptine Mesylate
- Busulfan
- Calcium Ipodate
- Cephalexin
- Chloramphenicol
- Chlorpromazine
- Codeine Phosphate
- Cyanocobalamin
- Danazol
- Dexchlorpheniramine
- Dextran 70
- Dextromethorphan
- Didanosine
- Dihydroergotamine
- Dithranol
- Ether
- Famotidine
- Flumazenil
- Flutamide
- Formaldehyde
- Glibenclamide
- Glucagon
- Hydroxyethyl starch (Hetastarch)
- Imipramine
- Indinavir
Page 111 of 117
Alphabetical List of Medicines Deleted from NLEM 2011
- Iodine
- Iopanoic Acid
- Iron dextran
- Lamivudine
- Losartan potassium
- Meglumine Iothalamate
- Meglumine Iotroxate
- Miconazole
- Mitomycin-C
- Multivitamins
- Nelfinavir
- Neomycin + Bacitracin
- Ofloxacin
- Olanzapine
- Piperazine
- Polygeline
- Procainamide
- Promethazine
- Propyliodone
- Pyridostigmine
- Pyrimethamine
- Raloxifene
- Saquinavir
- Sodium Iothalamate
- Sodium Stibogluconate
- Stavudine
- Sulfadiazine
- Sulfadoxine + Pyrimethamine
- Sulphacetamide sodium
- Terbutaline
- Testosterone
- Tetracaine hydrochloride
- Urokinase
- Vitamin D (Ergocalciferol)
- Zinc Oxide
INDEX
Aminosalicylic acid,
Fluorouracil,
-Mercaptopurine,
Abacavir,
Abacavir + Lamivudine, Acetazolamide, Acetylsalicylic acid, , , , Actinomycin D,
Activated charcoal, Acyclovir, , Adenosine, Adrenaline, Albendazole, Allopurinol, , All-trans retinoic acid, Alprostadil, Alteplase, Amiodarone, Amitriptyline, , Amlodipine, Amoxicillin,
Amoxicillin + Clavulanic acid, Amphotericin B, , Ampicillin,
Anti-D immunoglobulin, Anti-rabies immunoglobulin, Anti-tetanus immunoglobulin, Arsenic trioxide, Artemether + Lumefantrine, Artesunate,
Artesunate + Sulphadoxine – Pyrimethamine,
Ascorbic acid (Vitamin C),
Atazanavir + Ritonavir,
Atenolol,
Atorvastatin,
Atracurium,
Atropine, , ,
Azathioprine, ,
Azithromycin,
Baclofen,
Barium sulphate,
BCG vaccine,
Benzathine benzylpenicillin,
Benzoyl peroxide,
Benzyl penicillin,
Betamethasone, ,
Bicalutamide,
Bisacodyl,
Bleaching powder,
Bleomycin,
Bortezomib,
Budesonide, ,
Budesonide + Formoterol,
Bupivacaine,
Caffeine,
Calamine,
Calcium carbonate,
Calcium folinate,
Calcium gluconate, ,
Capecitabine,
Capreomycin,
Carbamazepine,
Carbimazole,
Carboplatin,
Carboxymethylcellulose,
Cefadroxil,
Cefazolin,
Cefixime,
Cefotaxime,
Ceftazidime,
Ceftriaxone,
Cetirizine,
Cetrimide,
Chlorambucil,
Chlorhexidine,
Chloroquine,
Chlorpheniramine,
Cholecalciferol,
Ciprofloxacin, , ,
Cisplatin,
Clarithromycin,
Page of
Clindamycin,
Dopamine,
Clobazam,
Doxorubicin,
Clofazimine,
Doxycycline,
Clomiphene,
DPT + Hib + Hep B vaccine,
Clomipramine,
DPT vaccine,
Clonazepam,
Efavirenz,
Clopidogrel,
Enalapril,
Clotrimazole, , ,
Enoxaparin,
Cloxacillin,
Entecavir,
Clozapine,
Erythromycin,
Coagulation factor IX,
Erythropoietin,
Coagulation factor VIII,
Escitalopram,
Coal tar,
Esmolol,
Colchicine,
Ethambutol,
Condom,
Ethinylestradiol,
Co-trimoxazole [Sulphamethoxazole +
Ethinylestradiol
- Levonorgestrel,
Trimethoprim ], ,
Ethinylestradiol
- Norethisterone,
Cryoprecipitate,
Ethionamide,
Cyclophosphamide,
Ethyl alcohol (Denatured),
Cycloserine,
Etoposide,
Cyclosporine,
Fentanyl,
Cytosine arabinoside,
Ferrous salt + Folic acid,
Dacarbazine,
Ferrous salts,
Dapsone,
Filgrastim,
Darunavir,
Fluconazole,
Daunorubicin,
Flunarizine,
Desferrioxamine,
Fluorescein,
Dexamethasone, , ,
Fluoxetine, , ,
Dextran-,
Fluphenazine,
Diazepam, ,
Folic acid,
Diclofenac,
Framycetin,
Dicyclomine,
Fresh frozen plasma,
Diethylcarbamazine,
Furosemide,
Digoxin,
Fusidic acid,
Diloxanide furoate,
Gadobenate,
Diltiazem,
Ganciclovir,
Dimercaprol,
Gefitinib,
Dinoprostone,
Gemcitabine,
Diphtheria antitoxin,
Gentamicin, ,
Dobutamine,
Glimepiride,
Docetaxel,
Glucose,
Domperidone,
Glucose + Sodium chloride,
Donepezil,
Glutaraldehyde,
Gycerin,
Glyceryl trinitrate,
Glycopyrrolate,
Griseofulvin,
Haemodialysis fluid,
Haloperidol, ,
Halothane,
Heparin, ,
Hepatitis B immunoglobulin, Hepatitis B vaccine, Homatropine,
Hormone releasing IUD,
Human chorionic gonadotropin,
Human normal immunoglobulin,
Hydrochlorothiazide, ,
Hydrocortisone, , ,
Hydrogen peroxide,
Hydroxocobalamin,
Hydroxychloroquine,
Hydroxypropyl methylcellulose,
Hydroxyurea,
Hyoscine butylbromide,
Ibuprofen,
Ifosfamide,
Imatinib,
Insulin (Soluble),
Intermediate Acting (NPH) Insulin,
Intraperitoneal dialysis solution,
Iohexol,
Ipratropium,
Iron sucrose,
Isoflurane,
Isoniazid,
Isosorbide dinitrate,
Isosorbide–mononitrate,
Ispaghula,
IUD containing Copper,
Japanese encephalitis vaccine,
Kanamycin,
Ketamine,
Labetalol,
Lactulose, ,
Lamivudine + Nevirapine + Stavudine,
Lamivudine + Zidovudine, L-Asparaginase, Leflunomide, Letrozole,
Levetiracetam,
Levodopa + Carbidopa,
Levofloxacin,
Levonorgestrel,
Levothyroxine,
Lignocaine
Lignocaine + Adrenaline,
Linezolid,
Lithium,
Loperamide,
Lopinavir + Ritonavir,
Lorazepam,
Magnesium sulphate,
Mannitol,
Measles vaccine,
Mebendazole,
Medroxyprogesteroneacetate,
Mefenamic acid,
Mefloquine,
Meglumine diatrizoate,
Melphalan,
Mesna,
Metformin,
Methotrexate, ,
Methyldopa,
Methylergometrine,
Methylprednisolone,
Methylrosanilinium chloride (Gentian Violet), ,
Methylthioninium chloride (Methylene blue),
Metoclopramide, ,
Metoprolol,
Metronidazole, ,
Midazolam, ,
Mifepristone,
Miltefosine,
Misoprostol,
Page of
Morphine, , ,
Moxifloxacin,
Mycophenolate mofetil,
N-acetylcysteine,
Naloxone,
Natamycin,
Neostigmine, ,
Nevirapine,
Nicotinamide,
Nifedipine,
Nitrofurantoin,
Nitrous oxide,
Nor adrenaline,
Norethisterone,
Nystatin,
Omeprazole,
Ondansetron, ,
Oral poliomyelitis vaccine,
Oral rehydration salts, ,
Oxaliplatin,
Oxygen,
Oxytocin,
Paclitaxel,
Pantoprazole, Para-aminosalicylic acid, Paracetamol, , Paromomycin,
Pegylated interferon alfa a/b,
Penicillamine,
Pentamidine,
Permethrin,
Pheniramine,
Phenobarbitone,
Phenylephrine,
Phenytoin,
Phytomenadione (Vitamin K),
Pilocarpine,
Piperacillin + Tazobactam, Platelet rich plasma, Podophyllin resin, Potassium chloride, Potassium permanganate, Povidone iodine, , ,
Pralidoxime chloride (-PAM), Praziquantel,
Prednisolone, , , , Premix Insulin : Injection
(Regular:NPH),
Prilocaine + Lignocaine,
Primaquine,
Procarbazine,
Proparacaine,
Propofol,
Propranolol,
Protamine,
Pyrazinamide,
Pyridoxine,
Quinine,
Rabies vaccine,
Raltegravir,
Ramipril,
Ranitidine,
Red blood cells,
Ribavirin,
Riboflavin,
Rifabutin,
Rifampicin, ,
Ringer lactate,
Risperidone,
Ritonavir,
Rituximab,
Salbutamol,
Salicylic acid,
Sevoflurane,
Silver sulphadiazine,
Snake venom antiserum, ,
Sodium bicarbonate,
Sodium chloride, Sodium nitrite, Sodium nitroprusside, Sodium thiosulphate, Sodium valproate, , Sofosbuvir, Somatostatin, Spironolactone, Stavudine + Lamivudine,
Streptokinase,
Streptomycin,
Succinylcholine,
Sucralfate,
Sulfasalazine,
Sumatriptan,
Surfactant,
Tacrolimus,
Tamoxifen,
Telmisartan,
Temozolomide,
Tenofovir,
Tenofovir + Lamivudine,
Tenofovir + Lamivudine + Efavirenz,
Tetanus toxoid,
Thalidomide,
Thiamine,
Thiopentone,
Timolol,
Tiotropium,
Tramadol, ,
Tranexamic acid,
Trastuzumab,
Trihexyphenidyl,
Tropicamide, ,
Tuberculin, Purified Protein derivative,
Vancomycin,
Vecuronium,
Verapamil,
Vinblastine,
Vincristine,
Vitamin A,
Warfarin,
Water for Injection,
White Petrolatum,
Whole blood,
Xylometazoline,
Zidovudine,
Zidovudine + Lamivudine + Nevirapine,
Zinc sulphate,
Zoledronic acid,
Zolpidem,